{
  "meta": {
    "title": "223_Medicine_Ini-Cet_2023",
    "url": "https://brainandscalpel.vercel.app/223-medicine-ini-cet-2023-4364d54f.html",
    "scrapedAt": "2025-11-30T12:57:06.359Z"
  },
  "questions": [
    {
      "text": "A patient in emergency has the following lab parameters: creatinine 1.5 and BUN 45. The chest x-ray is shown below. In gram staining and culture, only rhinovirus was isolated. The patient is shifted to ICU. What is the treatment of choice in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Azithromycin"
        },
        {
          "id": 2,
          "text": "Ceftriaxone plus azithromycin"
        },
        {
          "id": 3,
          "text": "Amoxicillin plus clavulanic acid"
        },
        {
          "id": 4,
          "text": "Piptaz plus ciprofloxacin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The chest radiograph is suggestive of <strong>pneumonia</strong>. Since this patient requires <strong>treatment in an ICU setting</strong>, the drugs of choice would be <strong>ceftriaxone plus azithromycin</strong>.</p>\n<p>Initial treatment in <strong>inpatients</strong> <strong>with pneumonia</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>Non-severe disease</td>\n<td>\n<p>A&nbsp;&beta;-lactam + a macrolide (ceftriaxone + azithromycin)</p>\n<p>or</p>\n<p>A respiratory fluoroquinolone</p>\n</td>\n</tr>\n<tr>\n<td>Severe disease</td>\n<td>\n<p>&nbsp;A&nbsp;&beta;-lactam + a macrolide (ceftriaxone + azithromycin)</p>\n<p>or&nbsp;</p>\n<p>A&nbsp;&beta;-lactam + respiratory fluoroquinolone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Appropriate antibiotics for <em>Pseudomonas aeruginosa</em> or MRSA are to be added if there is a history of prior isolation from respiratory samples.</p><hr><h3>Related Pearl: CURB-65 Criteria</h3><p>This is a score to determine the severity of pneumonia.</p>\n<p>The CURB-65 criteria include five variables(1 point for each variable):</p>\n<ul>\n<li><strong>C</strong>onfusion&nbsp;</li>\n<li>Blood <strong>U</strong>rea Nitrogen (BUN) &gt;7&nbsp;<span class=\"nowrap\">mmol/L</span></li>\n<li><strong>R</strong>espiratory rate &ge;30/min&nbsp;</li>\n<li><strong>B</strong>lood pressure, systolic &le;90 mmHg or diastolic &le;60 mmHg&nbsp;</li>\n<li>Age &ge;<strong>65</strong> years.</li>\n</ul>\n<p>Management:</p>\n<p><span class=\"medCalcFontOneBold\">0 point: Treat as an outpatient</span></p>\n<p><span class=\"medCalcFontOneBold\">1 to 2 points: Admitted to the hospital</span></p>\n<p><span class=\"medCalcFontOneBold\">&ge;3 points: ICU admission</span></p>\n<p><span class=\"medCalcFontOneBold\"><strong>Treatment of Community-Acquired Pneumonia</strong>&nbsp;</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 0: The drug of choice is macrolides. </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Azithromycin 500mg OD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Clarithromycin&nbsp; 500mg BD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Doxycycline&nbsp; 100mg BD.</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 1: Treated with azithromycin&nbsp; 500mg OD + ceftriaxone 2gm OD.</span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Respiratory quinolones (Levofloxacin) are not preferred. </span></p>\n<p><span class=\"medCalcFontOneBold\">Score - &gt;2: Azithromycin 500mg OD + Ceftriaxone 2gm IV OD and specific management.<br /></span></p>\n<p>NOTE:- In a<strong> modified </strong>version of the CURB-65, the criteria of blood urea nitrogen has been removed.</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;This elimination removes the need for lab testing.</p><hr><h3>Related Pearl: Empirical Antibiotic Treatment of Community-Acquired Pneumonia (CAP)</h3><table>\n<tbody>\n<tr>\n<td>Situation&nbsp;</td>\n<td>Treatment Regimen</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Outpatient</strong></td>\n<td>\n<p><strong>Previously healthy</strong>:</p>\n<p>&nbsp;Macrolide / Doxycycline</p>\n<p><strong>Comorbidities</strong>:</p>\n<p>Respiratory Fluoroquinolone&nbsp;</p>\n<p><strong>&nbsp; &nbsp; &nbsp; Or&nbsp;&nbsp;</strong>&nbsp; &nbsp; &nbsp;</p>\n<p>&beta;-lactam + Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>Non - ICU</strong></p>\n</td>\n<td>\n<p>Respiratory<strong>&nbsp;</strong>Fluoroquinolone&nbsp;</p>\n<p><strong>Or&nbsp;</strong></p>\n<p>&beta;-lactam&nbsp;<strong>+</strong>&nbsp;Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>ICU</strong></p>\n</td>\n<td>\n<p>&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Respiratory Fluoroquinolone <strong>Or</strong>&nbsp;Azithromycin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>If Pseudomonas</strong></p>\n&nbsp;</td>\n<td>\n<p><strong>&nbsp;</strong>Anti-pseudomonal&nbsp;&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Fluoroquinolone*&nbsp;<strong>Or</strong> Aminoglycoside</p>\n<p><strong>+ </strong></p>\n<p>Azithromycin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\"p1\"><strong>If CA-MRSA</strong></p>\n</td>\n<td>\n<p>Site based regimen</p>\n<p><strong>+</strong></p>\n<p>Linezolid <strong>Or&nbsp;</strong>Vancomycin</p>\n<p><strong>+</strong></p>\n<p>Clindamycin&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:</strong></p>\n<p>Macrolide - Azithromycin / Clarithromycin</p>\n<p>Fluoroquinolones :</p>\n<ul>\n<li>Respiratory Fluoroquinolone - Levofloxacin* / Moxifloxacin / (Gemifloxacin - only outpatient)&nbsp;</li>\n<li>Ciprofloxacin*</li>\n</ul>\n<p>&beta;-lactam :</p>\n<ul>\n<li>Outpatient with comorbidities&nbsp;\n<ul>\n<li>PO - Amoxicillin (+/- clavulanate)/ Cefpodoxime / Cefuroxime&nbsp;</li>\n<li>IV - Ceftriaxone</li>\n</ul>\n</li>\n<li>Inpatient, Non-ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin / Ceftriaxone / Cefotaxime / Ertapenem</li>\n</ul>\n</li>\n<li>Inpatient, ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin-Sulbactam / Ceftriaxone / Cefotaxime</li>\n</ul>\n</li>\n<li>Anti-pseudomonal&nbsp;&beta;-lactam (IV)&nbsp;\n<ul>\n<li>Piperacillin-Tazobactam / Cefepime / Imipenem / Meropenem&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p class=\"p1\">Aminoglycoside - Amikacin / T<span class=\"s1\">obramycin</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/82d1c5eb5e5e4e20b8e5a00893126b28.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9268",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with severe vomiting and diarrhea and has orthostatic hypotension. What metabolic abnormalities would you expect in this patient?<div class='question-desc-html'><ol>\n<li>Hypokalemia</li>\n<li>Hypochloremia</li>\n<li>Metabolic alkalosis</li>\n<li>Respiratory alkalosis</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 4 only"
        },
        {
          "id": 2,
          "text": "1, 3 only"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given clinical scenario, the patient is likely to have <strong>hypokalemia</strong>, <strong>hypochloremia</strong> and <strong>metabolic alkalosis</strong>.&nbsp;</p>\n<p>The given clinical scenario describes a patient who has a history of <strong>vomiting</strong> and <strong>diarrhea</strong> and now has <strong>orthostatic</strong> <strong>hypotension</strong>. This indicates that the patient is <strong>dehydrated</strong> and there is a <strong>contraction of the extracellular fluid volume</strong>. This would <strong>stimulate</strong> the <strong>renin-angiotensin-aldosterone system (RAAS)</strong>.</p>\n<p>Elevated aldosterone causes <strong>net H<sup>+</sup> and K<sup>+</sup> excretion</strong> from the distal tubule of the kidneys. This causes <strong>hypokalemia</strong> and <strong>metabolic alkalosis</strong>. Alkalosis is worsened because angiotensin II stimulates the Na<sup>+</sup>-H<sup>+</sup> exchanger in the renal proximal convoluted tubule and increases the reabsorption of Na<sup>+</sup> and HCO<sub>3</sub><sup>-</sup>.&nbsp;<strong>Hypochloremia</strong> occurs because of <strong>loss of HCl during vomiting</strong>, and is maintained due to <strong>loss of Cl<sup>-</sup> in the kidney</strong> which accompanies increased HCO<sub>3</sub><sup>-</sup> reabsorption.</p>\n<p>In a patient with metabolic alkalosis, the <strong>compensatory mechanism</strong> should be <strong>respiratory acidosis</strong>, not respiratory alkalosis (statement 4). This occurs in the form of <strong>hypoventilation</strong>, which increases PaCO<sub>2</sub>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9236",
      "difficulty": "easy"
    },
    {
      "text": "Order in which the following heart sounds are heard from superior to inferior on the left side chest wall?<div class='question-desc-html'><ol>\n<li>Pulmonary</li>\n<li>Aortic</li>\n<li>Mitral</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 → 1 → 2"
        },
        {
          "id": 2,
          "text": "3 → 2 → 1"
        },
        {
          "id": 3,
          "text": "2 → 1 → 3"
        },
        {
          "id": 4,
          "text": "1 → 2 → 3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The order of heart sounds as they are heard on the <strong>left chest wall</strong> from <strong>superior to inferior</strong> is as follows:</p>\n<ol>\n<li>Pulmonary&nbsp;&mdash; <strong>second</strong> intercostal space</li>\n<li>Aortic &mdash; can be auscultated in the neoaortic area or the <strong>Erb's point</strong>, in the <strong>third</strong> intercostal space&nbsp;</li>\n<li>Mitral&nbsp;&mdash; <strong>fifth</strong> intercostal space</li>\n</ol>\n<p>The following picture shows the areas of auscultation:</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d0478babe75543a6a202d8a2ce676329x978x960.PNG\" alt=\"Explanation Image\"><ol>\n<li><strong>Aortic area</strong>, <strong>second right intercostal space</strong>: this area is primarily used for auscultation of the aortic valve. The murmurs heard best here are those of <strong>aortic stenosis</strong>, <strong>aortic regurgitation,</strong> and hypertrophic cardiomyopathy.</li>\n<li><strong>Pulmonic area</strong>, <strong>second left intercostal space</strong>: this area is primarily used for the auscultation of the pulmonic valve.&nbsp;</li>\n<li><strong>Erb's point</strong>, <strong>third left intercostal space</strong>: this area lies close to both the semilunar valves. Pathologies of <strong>both aortic and pulmonic valves</strong> can be heard at this point. Murmurs in this region are <strong>more</strong> <strong>audible</strong> if the patient <strong>leans forward</strong>.</li>\n<li><strong>Tricuspid area</strong>, <strong>fourth left intercostal space</strong>: murmurs of <strong>tricuspid stenosis</strong> and <strong>tricuspid regurgitation</strong>, and <strong>ventricular septal defects</strong> are heard in this area.</li>\n<li><strong>Mitral area</strong>, <strong>fifth left intercostal space</strong> <strong>in the midclavicular line</strong>: murmurs of <strong>mitral stenosis</strong>, <strong>mitral regurgitation,</strong> and <strong>mitral valve prolapse</strong> are heard here.</li>\n</ol><hr><h3>Related Pearl: Heart sounds</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Heart Sound</strong></p>\n</td>\n<td>\n<p><strong>Frequency</strong></p>\n</td>\n<td>\n<p><strong>Duration</strong></p>\n</td>\n<td>\n<p><strong>Associated Event</strong></p>\n</td>\n<td>\n<p><strong>ECG Correlation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S1</p>\n</td>\n<td>\n<p>25-45 Hz</p>\n</td>\n<td>\n<p>0.15 sec</p>\n</td>\n<td>\n<p>Closure of AV Valves-Onset of Ventricular systole</p>\n</td>\n<td>\n<p>Later half of R wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S2</p>\n</td>\n<td>\n<p>50 Hz</p>\n</td>\n<td>\n<p>0.12 sec</p>\n</td>\n<td>\n<p>Closure of Semilunar Valves-Onset of ventricular diastole</p>\n</td>\n<td>\n<p>Later half of T wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S3</p>\n</td>\n<td>\n<p>Low</p>\n</td>\n<td>\n<p>0.1 sec</p>\n</td>\n<td>\n<p>First rapid filling phase of ventricular diastole</p>\n</td>\n<td>\n<p>Between the T and P wave</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S4</p>\n</td>\n<td>\n<p>Below 20 Hz</p>\n</td>\n<td>\n<p>0.1 sec</p>\n</td>\n<td>\n<p>Last rapid filling phase of ventricular diastole due to atrial contraction</p>\n</td>\n<td>\n<p>Following P wave</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9221",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old female presents with skin thickening, muscle weakness, and the peripheries becoming pale on exposure to cold. She is positive for ANA and anti-Scl-70 antibodies. Her creatinine kinase is elevated and muscle biopsy shows perifascicular infiltration. What is the antibody associated with this?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-U3 RNP"
        },
        {
          "id": 2,
          "text": "Anti-centromere antibody"
        },
        {
          "id": 3,
          "text": "Anti-PM-Scl antibody"
        },
        {
          "id": 4,
          "text": "Anti-Jo-1 antibody"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given patient with a history and findings suggestive of <strong>diffuse</strong> <strong>systemic sclerosis</strong> and <strong>dermatomyositis/polymyositis</strong> is most likely to be suffering from <strong>overlap syndrome</strong>. The presence of skin thickening, Reynaud's phenomenon, and anti-Scl-70 antibodies are suggestive of diffuse systemic sclerosis, while muscle weakness and perifascicular infiltration are suggestive of dermatomyositis/polymyositis.</p>\n<p>In overlap syndromes involving polymyositis/dermatomyositis and systemic sclerosis, <strong>anti-PM-Scl antibodies</strong> are found in <strong>close to 50%</strong> of the patients, while <strong>anti-Jo-1 antibodies</strong> were found to be positive in <strong>20-30%</strong> of the patients.</p>\n<p><strong>Anti-centromere antibodies</strong> (option B) are seen in <strong>limited-cutaneous systemic sclerosis</strong>. <strong>Anti-U3-RNP antibodies</strong> (also known as <strong>anti-fibrillin</strong> antibodies) are seen in both <strong>limited-cutaneous and diffuse systemic sclerosis</strong>. They signify an increased risk of the patient developing <strong>pulmonary arterial hypertension</strong>, interstitial lung disease, <strong>scleroderma renal crisis,</strong> and <strong>myositis</strong>.</p><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9281",
      "difficulty": "hard"
    },
    {
      "text": "During which phase of the cardiac cycle is an AR murmur likely to be heard?",
      "choices": [
        {
          "id": 1,
          "text": "Ventricular ejection"
        },
        {
          "id": 2,
          "text": "Throughout cardiac cycle"
        },
        {
          "id": 3,
          "text": "Isovolumetric contraction"
        },
        {
          "id": 4,
          "text": "Ventricular diastole"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Aortic regurgitation (AR)</strong> murmur is most likely to be heard during the <strong>ventricular diastole</strong>.&nbsp;</p>\n<p>On auscultation of patients with chronic AR, a high-pitched <strong>decrescendo diastolic murmur</strong> is heard. It can be best noted in the <strong>third intercostal space on the left sternal border</strong>. In patients with mild AR, the murmur is brief. But as the disease progresses, it becomes longer in duration, and can indeed become <strong>holodiastolic</strong>. In patients in whom <strong>AR</strong> <strong>is due to primary valvular disease</strong>, the diastolic murmur is <strong>heard louder on the left sternal border</strong>. However, if the <strong>murmur is louder on the right sternal border</strong>, it indicates that AR is due to aneurysmal <strong>dilation of the aortic root</strong>. The auscultatory features of AR are <strong>intensified</strong> <strong>by</strong>&nbsp;<strong>handgrip</strong>, which augments systemic vascular resistance and increases LV afterload.</p>\n<p>The heart murmurs heard in <strong>systole</strong> are:</p>\n<ul>\n<li><strong>Aortic and pulmonic stenosis</strong>: ejection systolic murmur</li>\n<li><strong>Chronic mitral and tricuspid regurgitation</strong>: holosystolic murmur</li>\n<li><strong>Mitral valve prolapse</strong>: midsystolic click followed by a late systolic murmur</li>\n<li><strong>Ventricular septal defect</strong>: holosystolic murmur</li>\n</ul>\n<p>The heart murmurs heard in <strong>diastole</strong> are:</p>\n<ul>\n<li><strong>Aortic regurgitation</strong>: early diastolic, decrescendo murmur</li>\n<li><strong>Mitral stenosis</strong>: opening snap following by mid to late diastolic murmur</li>\n</ul><hr><h3>Related Pearl: Dynamic auscultation of murmurs</h3><table>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(&uarr;venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(&uarr;afterload )</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of MR, AR, and VSD murmurs</li>\n<li>&darr; hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(&darr; preload)</p>\n</td>\n<td>\n<ul>\n<li>&darr; intensity of most murmurs (including AS)</li>\n<li>&uarr;&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(&uarr;venous return,&uarr;preload,<br />&uarr; afterload)</p>\n</td>\n<td>\n<ul>\n<li>&darr;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>&uarr;&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9217",
      "difficulty": "medium"
    },
    {
      "text": "Identify the given ECG.",
      "choices": [
        {
          "id": 1,
          "text": "Torsades de pointes"
        },
        {
          "id": 2,
          "text": "Ventricular fibrillation"
        },
        {
          "id": 3,
          "text": "Atrial flutter"
        },
        {
          "id": 4,
          "text": "Monomorphic ventricular tachycardia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given ECG shows <strong>broad QRS tachycardia</strong> with <strong>changing QRS morphology</strong> with every beat. The most likely diagnosis in this case is <strong>polymorphic ventricular tachycardia</strong> or <strong>Torsades de pointes</strong>.&nbsp;</p>\n<p>The causes of torsades de pointes include <strong>congenital long QT syndrome</strong>, electrolyte abnormalities (<strong>hypokalemia</strong>, hypomagnesemia, and hypocalcemia), certain <strong>drugs</strong>, cardiac conditions like <strong>myocardial infarction</strong> and myocarditis, and endocrine disorders like <strong>hypothyroidism</strong> and <strong>pheochromocytoma</strong>.&nbsp;</p><p>Other options:</p>\n<p><strong>Ventricular fibrillation</strong> (option B) shows a completely <strong>disorganized</strong> <strong>rhythm</strong> with <strong>no identifiable waves</strong> on ECG, as shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3e1674a501da4ad0a02ebe6bbb2ec36ax800x179.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Atrial flutter</strong> (option C) shows <strong>sawtooth appearance</strong> of the P-waves. This is due to rapid and successive atrial depolarization. The arrhythmia usually originates in the <strong>area of the tricuspid annulus in the right atrium</strong>. The ECG given below depicts atrial flutter, with the sawtooth P-waves most apparent in leads V1 and V2.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/212a3db2b9274b33a62dd163a91556e0x1280x878.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Monomorphic ventricular tachycardia</strong> (option D) shows <strong>wide QRS complex tachycardia</strong> but with the <strong>same QRS morphology</strong> in each beat. It occurs most commonly due to <strong>structural heart diseases</strong> (cardiomyopathy, or scarring after <strong>myocardial infarction</strong>). The patients are at high risk for sudden cardiac death. The ECG given below shows monomorphic ventricular tachycardia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f467a4b4800442cfaada3414cf118ad4x1088x570.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Drugs causing QT prolongation and torsades de pointes</h3><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br />&nbsp;</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/77afc941ea1f4500a09479604bee604c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9218",
      "difficulty": "easy"
    },
    {
      "text": "Total plasma exchange is done in thrombotic thrombocytopenic purpura. How does TPE help in the management of TTP?",
      "choices": [
        {
          "id": 1,
          "text": "TPE removes the von Willebrand factor"
        },
        {
          "id": 2,
          "text": "TPE removes the antiplatelet antibodies"
        },
        {
          "id": 3,
          "text": "TPE replenishes the coagulation factors"
        },
        {
          "id": 4,
          "text": "TPE removes anti-ADAMTS13 autoantibodies and thereby increases the ADAMTS protease activity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Therapeutic plasma exchange (TPE) <strong>removes autoantibodies to ADAMTS13</strong>. This makes ADAMTS13 enzyme functional and it is able to degrade multimers of von Willebrand factor.</p>\n<p><strong>Thrombotic thrombocytopenic purpura (TTP) </strong>is&nbsp;<strong>thrombotic microangiopathy</strong> that can be inherited or spontaneously acquired. It results from a <strong>deficiency of</strong>&nbsp;or <strong>antibodies to</strong> the metalloprotease <strong>ADAMTS13,&nbsp;</strong>which&nbsp;normally <strong>cleaves multimers</strong> of<strong>&nbsp;vWF</strong>. <strong>Failure to cleave</strong> these multimers results in <strong>excessive platelet adhesion </strong>and<strong> aggregation</strong>. This causes&nbsp;platelet thrombi and fibrin deposits to form at various sites in the circulation. These thrombi result in the <strong>classic pentad</strong> of clinical features:&nbsp;</p>\n<ul>\n<li>Microangiopathic hemolytic anemia (MAHA)</li>\n<li>Thrombocytopenia</li>\n<li>Renal failure</li>\n<li>Neurologic findings</li>\n<li>Fever</li>\n</ul>\n<p>The <strong>platelet thrombi narrow</strong> the vessel <strong>lumen,</strong>&nbsp;causing&nbsp;<strong>shearing stress</strong> on the red blood cells that are passing through. This results in microangiopathic hemolytic anemia. The same <strong>platelet thrombi&nbsp;</strong>cause <strong>microvascular occlusion</strong> and result in features like<strong> renal failure</strong> and <strong>neurological manifestations</strong>. On <strong>peripheral smear</strong>, these fragmented red cells appear as <strong>schistocytes</strong> or <strong>helmet cells,</strong> as shown in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7698db7a0b9c479d9e61b2dc0d1b4fd4x754x594.PNG\" alt=\"Explanation Image\"><p>The <strong>mainstay of treatment</strong> of TTP is with <strong>therapeutic plasma exchange (TPE)</strong>. TPE is continued till the platelet count becomes normal and signs of hemolysis are absent for at least 2 days. <strong>Glucocorticoids</strong> have been used as an adjunct to TPE. Addition of <strong>rituximab</strong> as an initial therapy also decreases the duration of TTP and relapses.</p><hr><h3>Related Pearl: Differences between TTP and HUS</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>TTP</strong></p>\n</td>\n<td>\n<p><strong>HUS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Causative agent</p>\n</td>\n<td>\n<p>A deficiency of, or antibodies to the metalloprotease ADAMTS13</p>\n</td>\n<td>\n<p>E. coli (O157: H7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI prodrome</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age group affected</p>\n</td>\n<td>\n<p>Adults</p>\n</td>\n<td>\n<p>Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex affected</p>\n</td>\n<td>\n<p>Females</p>\n</td>\n<td>\n<p>No sex predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relapses</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal impairment</p>\n</td>\n<td>\n<p>Usually mild</p>\n</td>\n<td>\n<p>Often severe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe thrombocytopenia</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Pentad of TTP and triad of HUS</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f1004c9ccec548288509c1eaed783d3fx1280x1840.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Indications of Plasma exchange Therapy</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Speciality</strong></p>\n</td>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurology</p>\n</td>\n<td>\n<p>Acute Guillain Barre syndrome</p>\n<p>Chronic inflammatory demyelinating polyneuropathy</p>\n<p>Myasthenia gravis</p>\n<p>Polyneuropathy associated with paraproteinaemias</p>\n<p>PANDAS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hematology</p>\n</td>\n<td>\n<p>Thrombotic thrombocytopenic purpura</p>\n<p>Atypical hemolytic-uraemic syndrome</p>\n<p>Hyperviscosity syndromes</p>\n<p>Severe/symptomatic cryoglobulinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal</p>\n</td>\n<td>\n<p>Goodpasture&rsquo;s syndrome</p>\n<p>Antineutrophil cytoplasmic antibody (ANCA)-associated rapidly progressive glomerulonephritis</p>\n<p>Recurrent focal segmental glomerular sclerosis</p>\n<p>Antibody-mediated renal transplant rejection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Metabolic</p>\n</td>\n<td>\n<p>Familial hypercholesterolemia</p>\n<p>Fulminant Wilson&rsquo;s disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9249",
      "difficulty": "easy"
    },
    {
      "text": "Identify the neurological test being performed.",
      "choices": [
        {
          "id": 1,
          "text": "Babinski sign"
        },
        {
          "id": 2,
          "text": "Ankle jerk"
        },
        {
          "id": 3,
          "text": "Jendrassik"
        },
        {
          "id": 4,
          "text": "Normal plantar response"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"notion-focusable\" tabindex=\"0\" role=\"button\">\n<div>&nbsp;</div>\n<div>The image shows <strong>extensor plantar response</strong>, which is a&nbsp;<strong>positive Babinski sign.</strong></div>\n<div>&nbsp;</div>\n<div>The <strong>normal response</strong> to uncomfortable or painful cutaneous stimulation of the file of the foot includes <strong>plantar flexion of the toes</strong>. This can be accompanied by flexion withdrawal of the limb. If there is an <strong>upper motor neuron lesion</strong> affecting the leg being tested, there will be an <strong>extensor plantar response</strong>, which is a <strong>positive Babinski sign</strong>. The <strong>minimum extensor response</strong> to be looked for is at least the <strong>extension of the great toe</strong>. It can be accompanied by <strong>fanning of other tows</strong> and contraction of the tensor fascia lata. Other features which may be seen in <strong>UMN lesions</strong> are <strong>spasticity of the leg</strong>, <strong>pathologically brisk reflexes,</strong> and <strong>ankle clonus.</strong></div>\n<div>&nbsp;</div>\n<div>The below image shows the positive and negative Babinski signs.</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b71e4bb1dd7c41d0ad038d6a6d1b2f68x407x358.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image below shows a <strong>positive Babinski sign</strong> in an <strong>adult</strong>, which is <strong>abnormal</strong> and indicative of a UMN lesion.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f82ba8377c714c94a44ed04ca8777aeex800x600.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>In <strong>infants</strong> whose <strong>corticospinal tracts</strong> are still <strong>underdeveloped</strong>, <strong>dorsiflexion of the great toe</strong> and fanning of other toes is a <strong>normal</strong> response to scratching of the sole of the foot. The image below shows an <strong>extensor</strong> response in an <strong>infant</strong>, which is normal.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da3ee900b2c54c2ca610b5c7e1b8d011x640x480.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Features of Motor Neuron Lesions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Upper Motor Neuron Lesion</strong></p>\n</td>\n<td>\n<p><strong>Lower Motor Neuron Lesion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Upper motor neuron typically refer to corticospinal tract neurons that innervate spinal motor neurons, but they can also include brainstem neurons that control spinal motor neurons</p>\n</td>\n<td>\n<p>Lower motor neurons are those whose axons terminate on skeletal muscles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Little or no muscle wasting&nbsp;&rarr; weakness of relatively large group of muscles</p>\n</td>\n<td>\n<p>Muscle atrophy &rarr; muscle weakness of an individual and specific muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertonia</p>\n</td>\n<td>\n<p>Hypotonia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increased or exaggerated deep tendon reflexes (hyperreflexia)</p>\n</td>\n<td>\n<p>Hyporeflexia or areflexia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spasticity</p>\n</td>\n<td>\n<p>Flaccidity</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Positive Babinski sign (abnormal plantar extensor reflex)</p>\n</td>\n<td>\n<p>Fasciculations</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7d952118d1e04fb19c63ead2dc637747.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9264",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following indicates severe COVID?",
      "choices": [
        {
          "id": 1,
          "text": "RR >24/min"
        },
        {
          "id": 2,
          "text": "MAP 70 mmHg"
        },
        {
          "id": 3,
          "text": "Lung infiltrates >42% on CT"
        },
        {
          "id": 4,
          "text": "SpO2 < 85% on room air"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>SpO2 &lt; 90% </strong>on room air indicates severe COVID.</p>\n<p>According to the clinical guidelines for the management of COVID-19 patients released by the <strong>AIIMS/ICMR task force</strong>, a <strong>respiratory rate of &gt;24/min</strong> constitutes <strong>moderate COVID</strong>, not severe COVID.&nbsp;</p>\n<p>According to the clinical management protocol given by the Ministry of Health and Family Welfare, the clinical severity of COVID-19 is given as:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Severity</strong></td>\n<td><strong>Presentation</strong></td>\n<td><strong>Clinical parameters</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td><strong>Mild</strong></td>\n<td>Uncomplicated URTI</td>\n<td>\n<p><strong>Mild symptoms</strong> such as fever, cough, sore throat and headache</p>\n<p>No shortness of breath or hypoxia: <strong>SpO<sub>2</sub>&nbsp;&ge; 94%&nbsp;</strong>on room air</p>\n</td>\n<td>Managed at home or COVID care center.</td>\n</tr>\n<tr>\n<td><strong>Moderate</strong></td>\n<td>Pneumonia with no signs of severe disease</td>\n<td>\n<p>Features of pneumonia</p>\n<p>Dyspnea or hypoxia present: <strong>SpO<sub>2</sub> 90 to&nbsp;&le; 93%</strong> on room air</p>\n<p><strong>Respiratory rate&nbsp;&ge; 24/min</strong></p>\n</td>\n<td>Managed at a dedicated COVID health center.</td>\n</tr>\n<tr>\n<td><strong>Severe</strong></td>\n<td>Severe pneumonia</td>\n<td>\n<p>Features of pneumonia</p>\n<p><strong>SpO2 &lt; 90% </strong>on room air</p>\n<p><strong>Respiratory rate &gt;30 breaths/min</strong></p>\n</td>\n<td>Managed at a dedicated COVID hospital.</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ARDS</td>\n<td>\n<p>As per ARDS diagnostic criteria</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Sepsis</td>\n<td>\n<p>Life-threatening <strong>organ dysfunction&nbsp;</strong></p>\n<p>Altered mental status, reduced urine output, weak pulse, cold extremities, <strong>weak blood pressure</strong>, coagulopathy</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Septic shock</td>\n<td><strong>Persistent hypotension despite volume resuscitation</strong>, requiring vasopressors to maintain MAP&nbsp;&ge; 65 mmHg</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b65dc115e4d2466995edb548aa173928x1280x4005.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9250",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are seen in iron deficiency anemia?<div class='question-desc-html'><ol>\n<li>Reduced serum iron level</li>\n<li>Reduced transferrin saturation</li>\n<li>Increased total iron binding capacity</li>\n<li>Reduced ferritin level</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2"
        },
        {
          "id": 2,
          "text": "3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Iron deficiency anemia</strong>&nbsp;(IDA) is characterized by <strong>reduced serum iron</strong> level, <strong>reduced transferrin saturation</strong>,&nbsp;<strong>increased total iron-binding capacity (TIBC),</strong> and <strong>reduced ferritin</strong> level.&nbsp;</p>\n<p><strong>Serum iron</strong> level represents the amount of <strong>circulating iron bound to transferrin</strong>. When the iron stores become depleted in IDA, the serum iron level begins to fall.&nbsp;</p>\n<p><strong>TIBC</strong> is an <strong>indirect measure</strong> of the circulating levels of the iron-transporting protein, <strong>transferrin</strong>. IDA is characterized by <strong>more free transferrin (not bound to iron)</strong> available in circulation. This increases the TIBC. <strong>Transferrin saturation</strong> is calculated as: (serum iron&nbsp;&divide; TIBC) x 100. Normal transferrin saturation is <strong>25-50%</strong>. <strong>Iron deficiency</strong> states show <strong>low transferrin saturation</strong>. A transferrin saturation &gt;50% indicates a large amount of iron being delivered to the tissues, and can cause tissue iron overload. This is seen in hemochromatosis.</p>\n<p><strong>Serum ferritin</strong> is the most useful laboratory test to assess the <strong>levels of iron stores</strong> in the body. As iron stores are depleted, serum ferritin levels fall. Levels <strong>&lt;15&nbsp;&mu;g/L</strong> are diagnostic of completely <strong>absent iron stores</strong>.</p><hr><h3>Related Pearl: Differential Diagnosis of Microcytic Anaemia</h3><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 &micro;g/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 &micro;g/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TIBC: Total iron-binding capacity&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9273",
      "difficulty": "easy"
    },
    {
      "text": "A patient recovered from hepatitis B infection. Which of the following curve represents antibodies seen 4 weeks post-recovery?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-HBs"
        },
        {
          "id": 2,
          "text": "Anti-HBc"
        },
        {
          "id": 3,
          "text": "HBeAg"
        },
        {
          "id": 4,
          "text": "HBsAg"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The serological marker marked in the image is <strong>anti-HBs antibody</strong>. In typical cases of resolving hepatitis B, HBsAg becomes undetectable 1-2 months after the appearance of clinical features. After this, anti-HBs becomes detectable in the serum.</p>\n<p>After a person is infected with the hepatitis B virus (HBV), the <strong>first</strong> <strong>serologic marker</strong> to increase in level is <strong>HBsAg.&nbsp;</strong>It becomes detectable in the serum between <strong>1-12 weeks.&nbsp;</strong>It becomes undetectable 1&ndash;2 months after the onset of jaundice and rarely persists beyond 6 months. Once the HBsAg becomes undetectable,&nbsp;anti-HBs antibody starts rising in serum and remains detectable indefinitely thereafter. The gap between the disappearance of HBsAg and the appearance of anti-HBs antibodies is called the <strong>window period.</strong>&nbsp;</p>\n<p><strong>HBcAg</strong> is located <strong>inside the cells</strong> and is usually enclosed within an HBsAg coat when present in the serum. As a result, HBcAg is <strong>not commonly detectable</strong> in the serum of patients with HBV infection since naked core particles are not found in the bloodstream. Conversely, <strong>anti-HBc</strong> can be detected in the serum shortly after the emergence of HBsAg, usually within <strong>1-2 weeks. Anti-HBc</strong>&nbsp;may be the only <strong>serologic marker</strong>&nbsp;useful for the identification of HBV infection during the <strong>window period.&nbsp;</strong></p>\n<p class=\"p1\"><strong>HBeAg</strong> appears shortly after the appearance of HBsAg. Its appearance correlates with high levels of <strong>virus replication. Anti-HBe</strong> correlates with a period of <strong>lower infectivity.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59d66670c07a481abcc0e406a52edd56x1280x1156.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/31aeec65e0c4450ebaab39c620fdc941.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5679",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a cause of reversible dementia?",
      "choices": [
        {
          "id": 1,
          "text": "B12 deficiency"
        },
        {
          "id": 2,
          "text": "Normal pressure hydrocephalus"
        },
        {
          "id": 3,
          "text": "Lewy body dementia"
        },
        {
          "id": 4,
          "text": "Hypothyroidism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lewy body dementia</strong> causes <strong>irreversible</strong> <strong>dementia</strong>.</p>\n<p><strong>Dementia&nbsp;</strong>is an acquired deterioration in cognitive abilities that impairs the successful performance of activities of daily living. The most commonly lost cognitive function is episodic memory, that is, the ability to recall events specific in time and place.</p>\n<p><strong>Causes of dementia are</strong>:</p>\n<p><strong>Reversible&nbsp;</strong></p>\n<ul>\n<li>Hypothyroidism</li>\n<li>Thiamine deficiency, vitamin B12 deficiency</li>\n<li>Normal pressure hydrocephalus</li>\n<li>Subdural hematoma</li>\n<li>Brain tumor</li>\n<li>Chronic infection</li>\n<li>Autoimmune encephalopathy</li>\n</ul>\n<p><strong>Irreversible&nbsp;</strong></p>\n<ul>\n<li>Alzheimer's disease</li>\n<li>Huntington's disease</li>\n<li>Lewy body dementia</li>\n<li>Vascular dementia</li>\n<li>Creutzfeld-Jacob disease</li>\n<li>Frontotemporal dementia</li>\n<li>Parkinson's disease</li>\n</ul><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9262",
      "difficulty": "easy"
    },
    {
      "text": "A female presented with excessive daytime sleepiness and impaired concentration and memory for one year. On examination, the BMI was 43 kg/m2 and BP was 170/98 mmHg. ABG was done in awake state and the findings are given below. Which of the following is the likely diagnosis?<div class='question-desc-html'><p>PaO<sub>2</sub>: 70 mmHg</p>\n<p>PaCO<sub>2</sub>: 53 mmHg</p>\n<p>HCO<sub>3</sub><sup>-</sup>: 33 mmHg</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Obesity hypoventilation syndrome"
        },
        {
          "id": 2,
          "text": "Obstructive sleep apnea"
        },
        {
          "id": 3,
          "text": "Central sleep apnea"
        },
        {
          "id": 4,
          "text": "Narcolepsy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of an obese patient with daytime sleepiness and hypercapnia on ABG is suggestive of <strong>obesity hypoventilation syndrome</strong>.</p>\n<p><strong>Obesity hypoventilation syndrome (OHS)</strong> occurs due to increased work of breathing, respiratory muscle impairment related to the increased load, and depressed central ventilatory response to hypoxemia and hypercapnia. The diagnosis of OHS requires:</p>\n<ul>\n<li><strong>BMI&nbsp;&ge;30 kg/m2</strong></li>\n<li><strong>PaCO2&nbsp;&ge;45 mmHg&nbsp;</strong>which&nbsp;signifies daytime alveolar hypoventilation</li>\n<li><strong>Evidence of sleep-disordered breathing</strong>, which in most cases is due to <strong>obstructive sleep apnea (OSA)</strong></li>\n</ul>\n<p><strong>Obstructive sleep apnea (OSA)</strong>&nbsp;(option B) is diagnosed if the patient has either symptoms of <strong>nocturnal breathing disturbances</strong> or <strong>daytime sleepiness</strong>, and<strong>&nbsp;&ge;5 episodes of obstructive apnea</strong> or hypopnea <strong>per hour of sleep</strong>. Each such episode should last for<strong> at least 10 seconds</strong>, resulting in&nbsp;&ge;3% drop in oxygen saturation or a brain cortical arousal. OSA is diagnosed by <strong>overnight polysomnogram (PSG)</strong>. This includes measurement of breathing, oxygenation, body position, cardiac rhythm, sleep stages, and snoring intensity. <strong>Waking hypoxemia or hypercarbia</strong> in a patient with OSA <strong>suggests</strong> cardiopulmonary disease or <strong>obesity hypoventilation syndrome</strong>.</p>\n<p><strong>Central sleep apnea (CSA)</strong>&nbsp;(option C) is caused due to increased sensitivity to PCO<sub>2</sub>. This causes an unstable breathing pattern which manifests as hyperventilation alternating with apnea. Prolonged circulation delay between pulmonary capillaries and carotid chemoreceptors is also a contributing cause. Hence, patients with heart failure may show CSA. They can present with <strong>Cheyne-Stokes breathing</strong>.&nbsp;</p>\n<p><strong>Narcolepsy</strong> (option D) presents with difficulty sustaining wakefulness and disturbed nocturnal sleep. However, unlike sleep apnea, patients with narcolepsy usually feel well-rested on awakening and then feel tired throughout the day. One of the most characteristic clinical features which is seen is <strong>cataplexy</strong>&nbsp;&ndash; sudden muscle weakness without a loss of consciousness, which is usually triggered by <strong>strong emotions</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9292",
      "difficulty": "medium"
    },
    {
      "text": "A patient with chronic kidney disease has the following laboratory reports. Calculate the anion gap in this patient.<div class='question-desc-html'><p>Na<sup>+</sup>: 145 mEq/L</p>\n<p>K<sup>+</sup>: 4 mEq/L</p>\n<p>Cl<sup>-</sup>: 90 mEq/L</p>\n<p>HCO<sub>3</sub><sup>-</sup>: 20 mEq/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "25"
        },
        {
          "id": 2,
          "text": "68"
        },
        {
          "id": 3,
          "text": "35"
        },
        {
          "id": 4,
          "text": "43"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The anion gap in this patient is 35 mEq/L.&nbsp;</p>\n<p>The <strong>anion gap</strong> is calculated as <strong>Na<sup>+</sup>&nbsp;&ndash; [Cl<sup>-</sup> + HCO<sub>3</sub><sup>-</sup>]</strong>. In this patient, the anion gap will be calculated as: 145&nbsp;&ndash; (90 + 20) = 145&nbsp;&ndash; 110 = 35 mEq/L.</p>\n<p><strong>Anion gap</strong> is representative of <strong>unmeasured anions</strong> which are normally present in the plasma, such as anionic proteins (<strong>albumin</strong>), <strong>phosphate</strong>, sulfate, and organic anions. When acid anions such as <strong>acetoacetate</strong> and <strong>lactate</strong> accumulate in the extracellular fluid, the <strong>anion gap increases</strong>, causing a <strong>high anion gap metabolic acidosis</strong>. A <strong>decrease</strong> <strong>in anion gap</strong> can occur due to an increase in abnormal cations (such as <strong>lithium</strong>, <strong>immunoglobulins</strong>), <strong>reduction in plasma albumin</strong> (<strong>nephrotic</strong> <strong>syndrome</strong>) or hyperviscosity and <strong>hyperlipidemia</strong>.</p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9223",
      "difficulty": "easy"
    },
    {
      "text": "A person comes to the OPD with symptoms of not using his left side and not washing the left side of his body while bathing. On examination, he wasn't able to draw the left side of the images. Which of the following is the most likely location of the lesion?",
      "choices": [
        {
          "id": 1,
          "text": "Left motor cortex"
        },
        {
          "id": 2,
          "text": "Left posterior parietal area"
        },
        {
          "id": 3,
          "text": "Right posterior parietal area"
        },
        {
          "id": 4,
          "text": "Right motor cortex"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given presentation and image suggest <strong>hemispatial neglect on the left side.</strong>&nbsp;This is likely due to a&nbsp;<strong>contralateral (right) parietal lobe lesion</strong>.</p>\n<div class=\"page\" title=\"Page 240\">The <strong>right hemisphere</strong> of the brain <strong>directs attention</strong> within the <strong>entire extrapersonal space</strong>&nbsp;&ndash; both right and left side. If there is a <strong>lesion in the left hemisphere</strong>, there is <strong>not much contralesional neglect</strong> because the right hemisphere can compensate for both sides. The <strong>left hemisphere</strong> <strong>directs</strong> <strong>attention</strong> only in the <strong>contralateral right hemispace</strong>. If there is a <strong>lesion in the right hemisphere</strong>, it leads to severe <strong>contralesional hemineglect</strong> because the left hemisphere does not contain ipsilateral attention functions.</div>\n<div class=\"page\" title=\"Page 240\">&nbsp;</div>\n<div class=\"page\" title=\"Page 240\">Patients with neglect may not be able to dress or groom the left side of the body. They may fail to copy the details on the left side of a drawing. Two bedside tests can be used to evaluate neglect:</div>\n<ul>\n<li>In<strong> simultaneous bilateral stimulation</strong>, when the examiner provides unilateral or simultaneous bilateral stimulation in the visual, auditory, or tactile modalities, patients have no difficulty detecting unilateral stimuli on either side but perceive the bilaterally presented stimulus as coming only from one side. This phenomenon is known as <strong>extinction</strong>.</li>\n<li>In<strong> visual target cancellation</strong>, the patient fails to detect the targets on one-half of the field in target-detection tasks.</li>\n</ul>\n<p>Other features of non-dominant pareital lobe lesions include:</p>\n<ul>\n<li>Constructional apraxia</li>\n<li>Visuo-spatial disorientation</li>\n<li>Dressing apraxia</li>\n</ul><hr><h3>Related Pearl: Brain lesions and disease</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Area of lesion</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>Dominant parietal cortex</td>\n<td>Agraphia, acalculia, finger agnosia, left-right disorientation</td>\n<td>Gerstmann syndrome</td>\n</tr>\n<tr>\n<td>Non-dominant parietal cortex</td>\n<td>Agnosia of the contralateral side of the world</td>\n<td>Hemispatial neglect syndrome</td>\n</tr>\n<tr>\n<td>Mammillary bodies<br />(bilateral)</td>\n<td>Confusion, Ataxia, Nystagmus, Ophthalmoplegia,<br />memory loss (anterograde and retrograde<br />amnesia), confabulation, personality changes.</td>\n<td>Wernicke-Korsakoff syndrome</td>\n</tr>\n<tr>\n<td>Amygdala (bilateral)</td>\n<td>hyperphagia, hypersexuality, hyperorality</td>\n<td>Kl&uuml;ver-Bucy syndrome</td>\n</tr>\n<tr>\n<td>Superior colliculus</td>\n<td>Paralysis of conjugate<br />vertical gaze (rostral interstitial nucleus also<br />involved)</td>\n<td>Parinaud syndrome</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c3453bd525c34a898981384957fc27b2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9251",
      "difficulty": "easy"
    },
    {
      "text": "Identify the type of ANA staining pattern shown in the image below.",
      "choices": [
        {
          "id": 1,
          "text": "Centromeric"
        },
        {
          "id": 2,
          "text": "Homogenous"
        },
        {
          "id": 3,
          "text": "Nucleolar"
        },
        {
          "id": 4,
          "text": "Speckled"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given picture shows <strong>discrete and large speckles</strong> in the resting cells, and the <strong>alignment of the speckles in the chromosome region</strong> in the <strong>dividing cells</strong>. This is suggestive of&nbsp;<strong>centromeric pattern</strong> of ANA staining. Centromeric pattern is seen in <strong>limited cutaneous systemic sclerosis (CREST syndrome)</strong>.</p><p>The main patterns of ANA staining are as follows:</p>\n<p><strong>Homogenous pattern</strong> refers to <strong>diffuse staining of the nucleus</strong> in the resting cells. There is also <strong>staining of the chromosome region in the dividing cells.&nbsp;</strong>The usual antibodies which show this pattern are <strong>anti-histone</strong> antibodies and <strong>anti-dsDNA</strong> antibodies. This type of pattern is also seen in <strong>chronic autoimmune hepatitis</strong> and <strong>juvenile idiopathic arthritis</strong>. Homogenous staining is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f73235ab6437490396ab35f8c321c744x720x665.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Fine speckled pattern</strong> refers to hundreds of <strong>dots present throughout the nucleus</strong>. However, there is <strong>no staining of the chromosome region</strong> of the dividing cells as shown in the image below. This pattern is shown by <strong>anti-SS-A/Ro</strong> and <strong>anti-SS-B/La</strong> antibodies.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8573e0862ac64070b1edcf9cfade216bx655x600.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Coarse speckled pattern</strong> refers to hundreds of <strong>dots present in the nucleus</strong>, but generally <strong>large</strong>r than the dots seen in fine speckled pattern. There is <strong>no staining of</strong> nucleoli or <strong>dividing chromosomes</strong>. This type of pattern is seen in <strong>anti-Sm</strong> and <strong>anti-U1 RNP</strong> antibodies.&nbsp;</p><p>&nbsp;</p>\n<p><strong>Dense fine speckled pattern</strong> shows the speckles distributed throughout the nucleoli. This pattern differs from the fine and coarse speckled patterns in that the <strong>speckles are associated with the chromosomes</strong> in the dividing cells. This type of pattern is<strong> not associated with systemic rheumatic disease</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0e20ecf10c4d47fba1f3b1f55681f2bax1280x1541.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Pattern of nuclear body suggests the type of antibody present in patient’s serum.</h3><p>Five basic patterns of nuclear fluorescence is recognized for anti-nuclear antibodies:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Staining pattern</strong></td>\n<td><strong>Antigen</strong></td>\n</tr>\n<tr>\n<td>Homogenous or diffuse nuclear staining</td>\n<td>Antibodies to <strong>chromatin, histones, </strong>and occasionally<strong> double-stranded DNA</strong></td>\n</tr>\n<tr>\n<td>Rim or peripheral staining</td>\n<td>Antibodies <strong>to double-stranded DNA, </strong>and sometimes to <strong>nuclear envelope proteins</strong></td>\n</tr>\n<tr>\n<td>Speckled pattern</td>\n<td>\n<p>One of the most commonly observed patterns of fluorescence, the least specific.&nbsp;</p>\n<p>Antibodies to non-DNA nuclear constituents such as <strong>Sm antigen, ribonucleoprotein, and SS-A and SS-B reactive antigens</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>Nucleolar pattern</td>\n<td>\n<p>Few discrete spots of fluorescence within the nucleus and represent&nbsp;<strong>antibodies to RNA</strong>.</p>\n<p><strong>Seen in systemic sclerosis.</strong></p>\n</td>\n</tr>\n<tr>\n<td>Centromeric pattern</td>\n<td>\n<p>Seen in systemic sclerosis</p>\n<p>Often contain antibodies specific for centromeres, which give rise to this pattern.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/79cff1e8d6244910afe4f779bd0d86aax1280x4885.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/28c2248db1424af399824ad21fe8756e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9202",
      "difficulty": "hard"
    },
    {
      "text": "A chronic cigarette smoker now joined a construction company. His pulmonary function test results are given below. What is the most likely diagnosis for this patient?<div class='question-desc-html'><p>Initial lung volumes were:<br />FEV1 - 0.9L<br />FVC - 1.9L<br />FEV1/FVC - 0.4</p>\n<p>After bronchodilation:<br />FEV1 - 1.9L<br />FVC - 3.9L<br />FEV1/FVC - 0.4</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Vascular disease with bronchodilator reversibility"
        },
        {
          "id": 2,
          "text": "Restrictive lung disease with bronchodilator reversibility"
        },
        {
          "id": 3,
          "text": "Restrictive lung disease without bronchodilator reversibility"
        },
        {
          "id": 4,
          "text": "Obstructive disease with bronchodilator reversibility"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given clinical scenario, <strong>FEV1/FVC</strong> is <strong>less than 0.7</strong>, hence it is <strong>obstructive</strong>. <strong>After bronchodilation</strong>, <strong>FEV1</strong> has increased from 0.9L to 1.9L, which is <strong>more than 12%</strong> implying its <strong>reversible</strong>. Therefore, the most likely diagnosis is an <strong>obstructive disease with bronchodilator reversibility</strong>.</p>\n<p>In <strong>obstructive</strong> pulmonary disease, <strong>FEV1/FVC </strong>is reduced to<strong> &lt;0.7</strong> and <strong>FEV1</strong> is also reduced <strong>&lt;80%</strong>. <strong>Reversibility</strong> is defined as a <strong>&ge;12% increase</strong> and <strong>absolute increase of 200mL</strong> in the <strong>FEV1</strong> at least 15 min <strong>after</strong> administration of a <strong>&beta;2 -agonist</strong>. Examples of obstructive pulmonary disease include COPD, asthma, bronchiectasis, etc.</p>\n<p>In<strong> restrictive</strong> pulmonary disease, <strong>FEV1/FVC</strong> is <strong>normal or increased</strong> ( &gt;0.7) and <strong>FEV1</strong><strong>&nbsp;</strong>and<strong> FVC</strong> are also <strong>reduced</strong>. Examples of restrictive pulmonary disease include asbestosis, sarcoidosis, idiopathic pulmonary fibrosis, etc. </p><hr><h3>Related Pearl: PFT for obstructive vs restrictive diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>PFT</strong></p>\n</td>\n<td>\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td>\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FVC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEV1</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td>\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td>\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEF 25-75</p>\n</td>\n<td>\n<p>&lt;50% predicted</p>\n</td>\n<td>\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TLC</p>\n</td>\n<td>\n<p>Normal/ increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RV</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DLCO</p>\n</td>\n<td>\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p><hr><h3>Related Pearl: Lung volumes and capacities</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Measurement</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Normal Value</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tidal volume (TV)</strong></p>\n</td>\n<td>\n<p>The amount of air that moves into the lungs with each inspiration (or the amount that moves out with each expiration) during quiet breathing</p>\n</td>\n<td>\n<p>500&ndash;750 mL.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory reserve volume&nbsp;</strong><strong>(IRV)</strong></p>\n</td>\n<td>\n<p>The air inspired with a maximal inspiratory effort in excess of the TV</p>\n</td>\n<td>\n<p>&sim;3 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory reserve volume (ERV)</strong></p>\n</td>\n<td>\n<p>The volume expelled by an active expiratory effort after passive expiration</p>\n</td>\n<td>\n<p>&sim;1.1 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Residual volume (RV)</strong></p>\n</td>\n<td>\n<p>The air left in the lungs after a maximal expiratory effort</p>\n</td>\n<td>\n<p>&sim;1.2 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total lung capacity (TLC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV+RV</p>\n</td>\n<td>\n<p>&sim;5.8 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vital capacity (VC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV</p>\n</td>\n<td>\n<p>&sim;4.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory capacity (IC)</strong></p>\n</td>\n<td>\n<p>TV+IRV</p>\n</td>\n<td>\n<p>&sim;3.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory capacity (EC)</strong></p>\n</td>\n<td>\n<p>TV+ERV</p>\n</td>\n<td>\n<p>&sim;1.6 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Functional residual capacity (FRC)</strong></p>\n</td>\n<td>\n<p>ERV+RV</p>\n</td>\n<td>\n<p>&sim;2.3 L</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/06c833b7f0ac40998f328de5bbe2816bx1279x973.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5086",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are true about subclinical myocarditis?<div class='question-desc-html'><ol>\n<li>Palpitations</li>\n<li>Elevated proBNP, Troponins</li>\n<li>Regional wall motion abnormalities in 2D echo</li>\n<li>ECG suggestive of myocarditis</li>\n<li>Low LVEF on 2D echo</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2"
        },
        {
          "id": 2,
          "text": "3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "2, 3, 4, 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A patient is diagnosed with <strong>possible subclinical acute myocarditis</strong> when there is a typical syndrome but <strong>without any cardiac symptoms</strong> such as palpitations. <strong>Biomarkers</strong> of cardiac injury are <strong>elevated</strong> (statement 2), <strong>ECG</strong> is <strong>abnormal</strong> (statement 4), and there is a <strong>reduced</strong> <strong>LV ejection fraction</strong> (statement 5) and <strong>regional wall motion abnormality</strong> on 2D echo (statement 3).&nbsp;</p>\n<p><strong>Probable acute myocarditis</strong> is diagnosed when the aforementioned criteria are <strong>accompanied by cardiac symptoms</strong> such as palpitations, shortness of breath, and chest pain. When there are <strong>signs of pericarditis</strong> along with elevated CK-MB or troponins and regional wall motion abnormalities, the term <strong>myopericarditis</strong> or <strong>perimyocarditis</strong> is used.</p>\n<p><strong>Definite myocarditis</strong> is diagnosed when there is <strong>histological evidence of inflammation</strong> on <strong>endomyocardial biopsy</strong>, and does not require any other laboratory or clinical criteria.</p><hr><h3>Related Pearl: Causes of Myocarditis</h3><p>Causes of myocarditis include:</p>\n<ul>\n<li>Infections:\n<ol>\n<li>Viruses (e.g., coxsackievirus, ECHO, influenza, HIV, cytomegalovirus)</li>\n<li>Chlamydiae (e.g., &nbsp;<em>Chlamydophila psittaci</em>)</li>\n<li>Rickettsiae (e.g., <em>Rickettsia typhi</em>, typhus fever)</li>\n<li>Bacteria (e.g., <em>Corynebacterium diphtheriae</em>, <em>Neisseria meningococcus</em>)</li>\n<li>Borrelia (Lyme disease)</li>\n<li>Fungi (e.g., <em>Candida </em>spp.)</li>\n<li>Protozoa (e.g., <em>Trypanosoma cruzi</em>&nbsp;[Chagas disease], toxoplasmosis)</li>\n<li>Helminths (e.g., trichinosis)</li>\n<li>Poststreptococcal (rheumatic fever)</li>\n<li>Immune-Mediated Reactions</li>\n<li>Systemic lupus erythematosus</li>\n</ol>\n</li>\n<li>Drug hypersensitivity (e.g., methyldopa, sulfonamides)</li>\n<li>Transplant rejection</li>\n<li>Sarcoidosis</li>\n<li>Giant cell myocarditis</li>\n<li>Unknown</li>\n</ul>\n<p>Morphology:</p>\n<p>The heart in myocarditis may appear normal or dilated. Some hypertrophy may be present depending on disease duration. Mural thrombi may be present. Active myocarditis is characterized by an interstitial inflammatory infiltrate associated with focal myocyte necrosis.&nbsp;<strong>Endomyocardial </strong><strong>biopsies are diagnostic in some cases, </strong>but <strong>not</strong> when the inflammation is <strong>focal or patchy.</strong></p>\n<p>The morphological pattern of myocarditis in certain conditions:</p>\n<ul>\n<li><strong>Hypersensitivity myocarditis: </strong>Interstitial infiltrates with a high proportion of eosinophils</li>\n<li><strong>Giant-cell myocarditis:</strong>&nbsp;Multinucleate giant cells (fused macrophages)</li>\n<li><strong>Chagas disease:</strong>&nbsp;Scattered myofibers by trypanosomes.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9220",
      "difficulty": "medium"
    },
    {
      "text": "A female with nephrotic syndrome underwent a renal biopsy. Which of the following statements is not correct?<div class='question-desc-html'><ol>\n<li>FSGS is not diagnosed by a percutaneous renal biopsy.</li>\n<li>Patient should be observed for 24 hours following biopsy.&nbsp;</li>\n<li>Dark red clots in the urine following a biopsy indicate a hematoma.</li>\n<li>Patients with features of systemic amyloidosis and renal involvement should undergo renal biopsy.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 2,
          "text": "4"
        },
        {
          "id": 3,
          "text": "1, 4"
        },
        {
          "id": 4,
          "text": "2, 3, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Patients undergoing a percutaneous kidney biopsy are <strong>observed for a 24-hour period</strong>&nbsp;(statement 2) in the hospital. If any major complication occurs, it is likely to happen during this period, and thus likely to be identified and treated early. <strong>Bleeding</strong> and <strong>hematoma formation</strong> are relatively common complications of kidney biopsy and can present as <strong>frank hematuria</strong> or <strong>dark red clots</strong> in the urine (statement 3).</p>\n<p><strong>Focal segmental glomerulosclerosis (FSGS)</strong> is a pathological diagnosis, so obtaining a tissue sample from kidney biopsy is necessary (statement 1). On light microscopy, there are <strong>focal</strong> (affecting only some of the glomeruli) and <strong>segmental</strong> (affecting only part of the glomerulus) lesions. There is a <strong>collapse of capillary loops</strong>, an increase in the matrix, and deposition of plasma proteins.</p>\n<p>In patients with features of <strong>systemic amyloidosis&nbsp;</strong>(statement 4), <strong>rectal</strong> or <strong>gingival</strong> <strong>tissues</strong> can be <strong>biopsied</strong> for the confirmation of the diagnosis. Examination of <strong>abdominal fat pat aspirates</strong> can also be used for confirmation of systemic amyloidosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9244",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following will not be measured to diagnose metabolic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "HDL levels "
        },
        {
          "id": 2,
          "text": "Hip circumference "
        },
        {
          "id": 3,
          "text": "Blood glucose"
        },
        {
          "id": 4,
          "text": "Blood pressure"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span><strong>Hip circumference</strong> is not used in the diagnosis of <strong>metabolic syndrome. </strong>Waist circumference is the parameter used.</span></p>\n<p><strong>Metabolic syndrome</strong><span> is present if </span><strong>three or more</strong><span> of the following five criteria are met, as defined by National Cholesterol Education Program and Adult Treatment Panel III </span><strong>(NCEP-ATP III):</strong></p>\n<ul>\n<li><strong>Central obesity</strong>: <strong>Waist circumference of &gt;102 cm in males</strong> and &gt;88 cm in females</li>\n<li><strong>Hypertriglyceridemia</strong>: Triglyceride level of <strong>≥ 150 mg/dL</strong></li>\n<li><strong>Low HDL</strong> cholesterol: <strong>&lt;40 mg/dL</strong> and &lt;50 mg/dL for men and women, respectively</li>\n<li><strong>Hypertension</strong>: Systolic BP of ≥130 mmHg or diastolic BP of ≥ 85 mmHg</li>\n<li><strong>Fasting plasma glucose level</strong>: ≥100 mg/dL or <strong>previously diagnosed type 2 diabetes</strong></li>\n</ul>\n<p><strong>BMI</strong> and <strong>LDL cholesterol </strong>levels are not part of <strong>NCEP-ATP III.</strong></p>\n<p>Metabolic syndrome (syndrome X) is a group of conditions that increases the risk for <strong>cardiovascular disease.</strong> These include <strong>hypertension,</strong> <strong>hyperglycemia,</strong> <strong>hypertriglyceridemia,</strong> and <strong>central obesity.</strong> Increasing age, genetics, and sedentary lifestyle are considered risk factors. </p>\n<p><strong>Insulin resistance</strong> is the most accepted hypothesis used to explain the pathophysiology of the condition. Elevated circulating fatty acids are considered a major factor in developing insulin resistance. It is associated with <strong>acanthosis nigricans</strong> which are <strong>velvety hyperpigmented</strong> lesions in <strong>skin flexures</strong> such as the axilla, groin, and back of the <strong>neck. </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1006",
      "difficulty": "medium"
    },
    {
      "text": "An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?",
      "choices": [
        {
          "id": 1,
          "text": "Furosemide"
        },
        {
          "id": 2,
          "text": "Carvedilol"
        },
        {
          "id": 3,
          "text": "Digoxin"
        },
        {
          "id": 4,
          "text": "Captopril"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of <strong>heart failure</strong>.<strong> ACE inhibitors </strong>like <strong>captopril</strong> are the first-line drugs to <strong>prevent</strong> further <strong>cardiac remodeling</strong> and prevent the <strong>progression</strong> of disease.</p>\n<p>Heart failure is a complex clinical syndrome that occurs because the <strong>ventricle</strong> is<strong> unable</strong> to<strong> fill</strong> with or <strong>eject blood</strong>. The important etiologies of heart failure include <strong>hypertension</strong>, diabetes mellitus, <strong>coronary artery disease</strong>, <strong>myocardial infarction</strong>, high output states, such as beriberi, thyrotoxicosis, and severe anemia.</p>\n<p>Clinical features of heart failure include <strong>dyspnea on exertion, orthopnea, pedal edema,</strong> anorexia, pallor, elevated JVP, ascites, and hepatomegaly.</p>\n<p>Heart failure is classified based on the <strong>ejection fraction</strong>:</p>\n<div class=\"page\" title=\"Page 87\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Heart failure with <strong>preserved ejection fraction</strong> <strong>(HFpEF) </strong>- left ventricular ejection fraction is <strong>≥50%</strong></li>\n<li>Heart failure with<strong> mid-range ejection fraction (HFmEF) - </strong>left ventricular ejection fraction <strong>40-50%</strong></li>\n<li>Heart failure with <strong>reduced ejection fraction (HFrEF) </strong>- left ventricular ejection fraction is <strong>≤40%</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>The mainstay management of heart failure is medical therapy and device therapy is reserved for refractory cases. The type of medications used in medical therapy are:</p>\n<ul>\n<li>Drugs with <strong>symptomatic</strong> and <strong>mortality benefits</strong> provide symptomatic relief and reduce mortality risk by <strong>preventing cardiac remodeling</strong>. It includes - \n<ul>\n<li aria-level=\"2\">Angiotensin receptor–neprilysin inhibitor (ARNI) - a combination of <strong>sacubitril</strong> and <strong>valsartan</strong></li>\n<li aria-level=\"2\">Angiotensin-converting enzyme (ACE) inhibitors - ramipril, <strong>enalapril</strong></li>\n<li aria-level=\"2\">β-blockers -<strong> metoprolol</strong>, carvedilol, bisoprolol</li>\n<li aria-level=\"2\">Mineralocorticoid receptor antagonist -<strong> spironolactone</strong>, eplerenone</li>\n<li aria-level=\"2\">Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitor) -<strong> dapagliflozin</strong></li>\n</ul>\n</li>\n<li>Drugs with only symptomatic benefits provide only symptomatic relief and have no effect on reducing mortality risk. It includes - \n<ul>\n<li>Loop diuretics - <strong>furosemide</strong></li>\n<li><strong>Digoxin</strong></li>\n</ul>\n</li>\n</ul>\n<p>Unfortunately, evidence of the clinical benefits of most therapies is restricted to <strong>HFrEF</strong>. Pharmacological therapy used in <strong>HFpEF</strong> is mainly <strong>diuretics</strong>.</p>\n<p><strong>Non-pharmacological therapy</strong> includes <strong>implantable cardioverter defibrillators (ICD), </strong><strong>cardiac resynchronization</strong> using biventricular pacing, etc. These treatments are not found to be effective in HFpEF.</p><hr><h3>Related Pearl: Summary of Pathogenesis of Major Findings in Congestive Heart Failure</h3><p><strong>Summary of Pathogenesis of Major Findings in Congestive Heart Failure</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Abnormality</strong></p>\n</td>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Weakness, exercise intolerance, fatigue</p>\n</td>\n<td>\n<p>Left ventricle output inadequate to perfuse muscles; especially, failure of output to rise with exercise</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ankle, sacral edema</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased fluid transudation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatomegaly</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased resistance to portal flow.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary congestion</p>\n</td>\n<td>\n<p>Increased pulmonary venous pressure &rarr;pulmonary venous distention and transudation of fluid into air spaces</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dyspnea on exertion</p>\n</td>\n<td>\n<p>Failure of left ventricular output to rise during exercise &rarr; increased pulmonary venous pressure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paroxysmal dyspnea, pulmonary edema</p>\n</td>\n<td>\n<p>Probably a sudden failure of left heart output to keep up with the right heart output &rarr;acute rise in pulmonary venous and capillary pressure &rarr;transudation of fluid into air spaces.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Orthopnea</p>\n</td>\n<td>\n<p>Normal pooling of blood in lungs in supine position added to the already congested pulmonary vascular system; increased venous return not put out by the left ventricle. (Relieved by sitting up, raising the head of the bed, lying on extra pillows.)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiac dilation</p>\n</td>\n<td>\n<p>Greater ventricular end-diastolic volume.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Drugs used in heart failure</h3><div>Drugs used in<strong> acute decompensated heart failure:</strong></div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous vasodilators</strong></td>\n</tr>\n<tr>\n<td>\n<p>Nitroglycerine</p>\n<p>Sodium nitroprusside</p>\n</td>\n<td>Decrease preload and afterload</td>\n</tr>\n<tr>\n<td>Nesiritide</td>\n<td>Recombinant human BNP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous positive inotropes</strong></td>\n</tr>\n<tr>\n<td>\n<p>Dobutamine</p>\n<p>Dopamine</p>\n<p>Epinephrine</p>\n<p>Norepinephrine</p>\n</td>\n<td>&beta;1 receptor-mediated stimulation of cardiac output</td>\n</tr>\n<tr>\n<td>\n<p>Enoximone</p>\n<p>Milrinone</p>\n</td>\n<td>PDE 3/4 inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Levosimendan</p>\n<p>Pimobendan</p>\n</td>\n<td>Combined Ca<sup>2+</sup> sensitizers and PDE3 inhibitors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Drugs used for rapid symptom relief</strong></td>\n</tr>\n<tr>\n<td>\n<p>Bumetanide</p>\n<p>Furosemide</p>\n<p>Torasemide</p>\n</td>\n<td>Loop diuretics- used for symptomatic treatment of severe heart failure and acute decompensation.</td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Opioid - to calm the patient and decreases cardiac O2 consumption</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>Drugs used in<strong> chronic heart failure:</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>ACE inhibitors</td>\n<td>Used as first-line therapy</td>\n</tr>\n<tr>\n<td>ARBs</td>\n<td>Used in case of intolerance to ACE inhibitors</td>\n</tr>\n<tr>\n<td>Beta-blockers</td>\n<td>Used as first-line therapy &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Spironolactone</p>\n<p>Eplerenone</p>\n</td>\n<td>Mineralocorticoid receptor antagonists - first-line drugs for symptomatic heart failure.</td>\n</tr>\n<tr>\n<td>SGLT-2 inhibitors</td>\n<td>Used as 1st line therapy- reduces mortality and morbidity</td>\n</tr>\n<tr>\n<td>Sacubitril/Valsartan</td>\n<td>Neprilysin inhibitor/ARB(ARNI)</td>\n</tr>\n<tr>\n<td>Ivabradine</td>\n<td>Inhibitor of I<sub>f</sub>&nbsp;current in the sinoatrial node</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1086",
      "difficulty": "hard"
    },
    {
      "text": "A 27-year-old female patient presents with weight loss, anxiety, tachycardia, and restlessness. The resting pulse was 110 beats per minute. Which of the following tests should be done to evaluate her condition further?",
      "choices": [
        {
          "id": 1,
          "text": "Total T3"
        },
        {
          "id": 2,
          "text": "TPO"
        },
        {
          "id": 3,
          "text": "Thyroid Scan"
        },
        {
          "id": 4,
          "text": "TSH and free T4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This patient is presenting with symptoms of <strong>hyperthyroidism.</strong> The next step in diagnosis would be to obtain a serum <strong>TSH</strong> level and Free T4 level. </p>\n<p><span data-preserver-spaces=\"true\">Investigations in a patient with <strong>Graves'</strong> disease</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\"><strong>Thyroid function tests</strong>- In Graves disease, the thyroid-stimulating hormone (<strong>TSH</strong>) levels are <strong>decreased</strong> with or without elevated T3 and T4 levels. It is the first step in evaluating suspected thyroid disease.</span></li>\n<li><span data-preserver-spaces=\"true\"><strong>Anti-thyroid antibodies</strong>-<strong> </strong>Elevated levels of <strong>TSH receptor antibodies</strong> are <strong>diagnostic</strong> of Graves' disease. Other antibodies like anti-Tg and anti-TPO are elevated in most of the patients. </span></li>\n<li><span data-preserver-spaces=\"true\"><strong>Ultrasound</strong> of the neck is performed to evaluate vascularity, echogenicity, nodules, and clinical <strong>landmarks</strong> for surgical planning. </span></li>\n<li class=\"p1\">CT or MRI scans of the orbits are useful to evaluate Graves’ ophthalmopathy.</li>\n</ul>\n<p><span data-preserver-spaces=\"true\">The hyperthyroidism of Graves’ disease is caused by </span><strong><span data-preserver-spaces=\"true\">thyroid-stimulating immunoglobulin (TSI)</span></strong><span data-preserver-spaces=\"true\"> that are synthesized in the thyroid gland as well as in bone marrow and lymph nodes. TSI antibodies cause stimulation of the thyroid gland causing features of hyperthyroidism in the presence of low TSH levels. Histopathology</span><span data-preserver-spaces=\"true\"> shows </span>follicular and papillary hyperplasia with lymphoid infiltration. </p>\n<p><span data-preserver-spaces=\"true\">A patient with Graves' disease will present with complaints of:</span></p>\n<ul>\n<li><strong>H</strong><span data-preserver-spaces=\"true\"><strong>yperactivity,</strong> irritability</span></li>\n<li><span data-preserver-spaces=\"true\">Heat intolerance and sweating</span></li>\n<li><strong>Palpitations</strong></li>\n<li><strong>Weakness</strong></li>\n<li><span data-preserver-spaces=\"true\">Weight loss with increased appetite</span></li>\n<li><strong>Diarrhea</strong></li>\n<li><span data-preserver-spaces=\"true\">Polyuria, oligomenorrhea, and loss of libido.</span></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">On examination, they may have</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">Tachycardia</span></li>\n<li><span data-preserver-spaces=\"true\">Exophthalmos</span></li>\n<li><span data-preserver-spaces=\"true\">Lid retraction or lag</span></li>\n<li><span data-preserver-spaces=\"true\">Goiter</span></li>\n<li><span data-preserver-spaces=\"true\">Tremor </span></li>\n<li><span data-preserver-spaces=\"true\">Gynecomastia </span></li>\n<li><span data-preserver-spaces=\"true\">Myopathy. </span></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">Other options: <strong>TPO,</strong> Serum <strong>T3</strong> and <strong>thyroid scans</strong> are obtained only after serum TSH is obtained to confirm the diagnosis. But the first step remains measuring <strong>TSH</strong> levels. </span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6914",
      "difficulty": "easy"
    },
    {
      "text": "A 65-year-old man was brought after a fall.  He has a fever and confusion. On examination, he had a cough with rales. The patient was also tachypneic. How will you manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Admit and give Oral levofloxacin"
        },
        {
          "id": 2,
          "text": "Treat at home and oral augmentin"
        },
        {
          "id": 3,
          "text": "Admit and iv ceftriaxone"
        },
        {
          "id": 4,
          "text": "Admit and give IV levofloxacin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario of a patient with <strong>fever</strong> and <strong>productive cough</strong> point to a diagnosis of <strong>pneumonia</strong>. Since this <strong>patient's CURB-65 score</strong> is at least <strong>3</strong> (1 point each for confusion, tachyapnea, and Age 65), the <strong>most appropriate management</strong> would be <strong>ICU admission</strong> and starting<strong> IV antibiotics</strong>. This patient with a score of 3 will need ICU admission and treatment with a respiratory quinolone like <strong>levofloxacin.</strong> </p>\n<p>Once the diagnosis of pneumonia is made, the next step in management is to <strong>determine the site of care </strong>for the patient. To identify the patients that require in-patient and ICU management,<strong> CURB-65 score</strong> is used. It includes:</p>\n<ul>\n<li><strong>C</strong>onfusion</li>\n<li><strong>U</strong>rea ≥ 20 mg/dL</li>\n<li><strong>R</strong>espiratory rate ≥30/min</li>\n<li><strong>B</strong>lood pressure: SBP ≤90mmHg or DBP ≤60 mmHg</li>\n<li>Age ≥ <strong>65</strong> years</li>\n</ul>\n<p><strong>1 point</strong> is given for the presence of each of the above. The<strong> total score determines the site of care</strong>, as shown below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Total Score</strong></td>\n<td><strong>Decision</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>Outpatient treatment</td>\n</tr>\n<tr>\n<td>1 or 2</td>\n<td>Inpatient treatment in non-ICU setting</td>\n</tr>\n<tr>\n<td>≥3</td>\n<td>Inpatient treatment in ICU setting</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Note: Treatment with a combination of Beta-lactam and a macrolide or <strong>a respiratory fluoroquinolone alone</strong> results in <strong>lower mortality</strong> than monotherapy with a beta-lactam antibiotic. Therefore, out of the given options, D is the best answer. </p><hr><h3>Related Pearl: Empirical Antibiotic Treatment of Community-Acquired Pneumonia (CAP)</h3><table>\n<tbody>\n<tr>\n<td>Situation&nbsp;</td>\n<td>Treatment Regimen</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Outpatient</strong></td>\n<td>\n<p><strong>Previously healthy</strong>:</p>\n<p>&nbsp;Macrolide / Doxycycline</p>\n<p><strong>Comorbidities</strong>:</p>\n<p>Respiratory Fluoroquinolone&nbsp;</p>\n<p><strong>&nbsp; &nbsp; &nbsp; Or&nbsp;&nbsp;</strong>&nbsp; &nbsp; &nbsp;</p>\n<p>&beta;-lactam + Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>Non - ICU</strong></p>\n</td>\n<td>\n<p>Respiratory<strong>&nbsp;</strong>Fluoroquinolone&nbsp;</p>\n<p><strong>Or&nbsp;</strong></p>\n<p>&beta;-lactam&nbsp;<strong>+</strong>&nbsp;Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>ICU</strong></p>\n</td>\n<td>\n<p>&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Respiratory Fluoroquinolone <strong>Or</strong>&nbsp;Azithromycin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>If Pseudomonas</strong></p>\n&nbsp;</td>\n<td>\n<p><strong>&nbsp;</strong>Anti-pseudomonal&nbsp;&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Fluoroquinolone*&nbsp;<strong>Or</strong> Aminoglycoside</p>\n<p><strong>+ </strong></p>\n<p>Azithromycin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\"p1\"><strong>If CA-MRSA</strong></p>\n</td>\n<td>\n<p>Site based regimen</p>\n<p><strong>+</strong></p>\n<p>Linezolid <strong>Or&nbsp;</strong>Vancomycin</p>\n<p><strong>+</strong></p>\n<p>Clindamycin&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:</strong></p>\n<p>Macrolide - Azithromycin / Clarithromycin</p>\n<p>Fluoroquinolones :</p>\n<ul>\n<li>Respiratory Fluoroquinolone - Levofloxacin* / Moxifloxacin / (Gemifloxacin - only outpatient)&nbsp;</li>\n<li>Ciprofloxacin*</li>\n</ul>\n<p>&beta;-lactam :</p>\n<ul>\n<li>Outpatient with comorbidities&nbsp;\n<ul>\n<li>PO - Amoxicillin (+/- clavulanate)/ Cefpodoxime / Cefuroxime&nbsp;</li>\n<li>IV - Ceftriaxone</li>\n</ul>\n</li>\n<li>Inpatient, Non-ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin / Ceftriaxone / Cefotaxime / Ertapenem</li>\n</ul>\n</li>\n<li>Inpatient, ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin-Sulbactam / Ceftriaxone / Cefotaxime</li>\n</ul>\n</li>\n<li>Anti-pseudomonal&nbsp;&beta;-lactam (IV)&nbsp;\n<ul>\n<li>Piperacillin-Tazobactam / Cefepime / Imipenem / Meropenem&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p class=\"p1\">Aminoglycoside - Amikacin / T<span class=\"s1\">obramycin</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1093",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old with a history of COPD is brought to the ER with worsening dyspnea. ABG was done and pH was 7.3, pCO2 was 60mmHg with HCO3- being 28 mEq/L. Which of the following is seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Respiratory acidosis, hyperventilation, inadequate metabolic compensation"
        },
        {
          "id": 2,
          "text": "Respiratory alkalosis, hypoventilation, inadequate metabolic compensation"
        },
        {
          "id": 3,
          "text": "Respiratory acidosis, hypoventilation, inadequate metabolic compensation"
        },
        {
          "id": 4,
          "text": "Respiratory acidosis, hypoventilation, adequate metabolic compensation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The arterial blood gas values suggest a likely diagnosis of <strong>respiratory acidosis </strong>(pH of 7.3 and elevated PaCO2 of 60mmHg indicating inadequate respirations). Normal serum bicarbonate levels are 22-26mEq/L indicating that this patient's acidosis is inadequately compensated.</p>\n<p>The various buffering systems present in the body maintain the systemic arterial pH between <strong>7.35-7.45</strong>. The most common acid-base disorders are metabolic acidosis or alkalosis and respiratory acidosis or alkalosis.</p>\n<p>Normal values in an arterial blood gas are as follows:</p>\n<ul>\n<li>pH: 7.35-7.45</li>\n<li class=\"half_rhythm\">\n<div>PaCO<sub>2</sub>: 35-45 mmHg</div>\n</li>\n<li class=\"half_rhythm\">\n<div>HCO<sub>3</sub>: 22-26 mEq/L</div>\n</li>\n<li class=\"half_rhythm\">\n<div>PaO<sub>2</sub>: 75-100 mmHg</div>\n</li>\n</ul>\n<p>Respiratory changes (changes in PCO<sub>2</sub>) promote a corresponding change in metabolic response (changes in HCO<sup>3-</sup>) and vice versa as a <strong>compensatory mechanism</strong>. In general, PCO<sub>2</sub> and HCO<sup>3-</sup> move in the <strong>same direction</strong> for compensation in metabolic and respiratory acid-base disorders respectively. A change in the two parameters in <strong>opposite directions</strong> points to a <strong>mixed acid-base disturbance</strong>. </p>\n<p>Respiratory acidosis can be secondary to severe pulmonary disease, respiratory muscle fatigue, or ventilatory control abnormalities. It is marked by an <strong>increase</strong> in PaCO<sub>2</sub> and a <strong>decrease</strong> in<strong> pH</strong>. A compensatory <strong>rise</strong> of <strong>HCO<sup>3-</sup></strong> can also be seen. </p>\n<p>A rapid rise in PCO<sub>2</sub> (acute hypercapnia) can present with <strong>dyspnea</strong>, <strong>confusion</strong>, and psychosis. It can be seen in severe asthma secondary to bronchospasm, anaphylaxis, or inhalational burns. Chronic hypercapnia causes sleep disorders, memory loss, and daytime somnolence. It is commonly seen in end-stage <strong>obstructive lung disease</strong>. </p>\n<p>Acute respiratory acidosis may need <strong>tracheal intubation</strong> and assisted <strong>mechanical ventilation</strong>. Rapid correction of hypercapnia should be avoided as it can trigger cardiac arrhythmias and seizures. Chronic respiratory acidosis is difficult to manage and improvement in lung function is the primary aim. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cea77858973342d1816320d43c36b6b1x1280x1555.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Expected compensation in acid-base disorders</h3><table>\n<tbody>\n<tr>\n<td>Primary disorder</td>\n<td>Expected compensation</td>\n</tr>\n<tr>\n<td>Metabolic acidosis</td>\n<td>\n<p>Expected PaCO<sub>2</sub> = [1 .5 X HCO<sub>3</sub><sup>-</sup>] + 8 &plusmn; 2; or</p>\n<p>&darr; PaCO2 = 1.25 x &Delta;HCO3</p>\n</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Increase in PaCO<sub>2 </sub>= 0.75 x &Delta;HCO<sub>3</sub><sup>-</sup></td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory acidosis</p>\n</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.1 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.003 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.2 x &Delta; PaCO<sub>2</sub></p>\n<p>&uarr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Interpretation of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1075",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presented with acute onset of chest pain radiating to the left arm and diaphoresis. His ECG and cardiac biomarkers show non-ST elevation myocardial infarction. Which of the following will be used in the treatment of this patient?<div class='question-desc-html'><ol>\n<li>Atorvastatin</li>\n<li>Aspirin</li>\n<li>Clopidogrel</li>\n<li>Low molecular weight heparin</li>\n<li>Alteplase</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3"
        },
        {
          "id": 2,
          "text": "4, 5"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>While <strong>atorvastatin</strong>, <strong>aspirin</strong>, <strong>clopidogrel</strong>, and <strong>low molecular weight heparin</strong> all have a <strong>role in the management of</strong> a patient with <strong>NSTEMI</strong>, there is <strong>no role of alteplase</strong>. </p>\n<p><strong>Initial</strong> <strong>management</strong> of a patient with NSTEMI includes <strong>bed rest</strong> to decrease the load on the heart. <strong>Oxygen</strong> is administered <strong>only if</strong> the patient has <strong>hypoxemia</strong> (SpO<sub>2</sub> &lt;90%) <strong>or heart failure</strong>. Further management includes the following medical therapy:</p>\n<p><strong>Nitrates</strong> (such as <strong>nitroglycerine</strong> given <strong>sublingually</strong>) <strong>reduce the venous return</strong> to the heart, thus reducing the cardiac output and the oxygen demand. Nitrates are <strong>contraindicated</strong> <strong>if</strong> the patient has <strong>hypotension</strong>. </p>\n<p><strong>β-blockers</strong> also <strong>reduce</strong> the <strong>myocardial oxygen demand</strong> predominantly by their negative chronotropic effect. <strong>Diltiazem</strong> or <strong>verapamil</strong> are given to reduce the heart rate <strong>if</strong> the patient <strong>doesn't respond to β-blockers</strong>. </p>\n<p><strong>Morphine</strong> is given <strong>if</strong> the <strong>patient</strong> <strong>continues</strong> <strong>to have severe chest pain</strong> despite the administration of the abovementioned anti-ischemic drugs.</p>\n<p><strong>Antithrombotic therapy</strong>, which includes:</p>\n<ul>\n<li><strong>Dual antiplatelet therapy (DAPT)</strong> with <strong>aspirin</strong> and a P2Y<sub>12</sub> blocker such as <strong>clopidogrel.</strong> DAPT is continued for a minimum of 3 months, but preferably for 12 months. </li>\n<li><strong>Anticoagulants</strong> such as <strong>low molecular weight heparin</strong> and bivalirudin </li>\n</ul>\n<p>Clot formation and fibrinolysis is a dynamic process occurring in the coronary arteries. Antithrombotic therapy is given to prevent new clot formation while fibrinolysis is occurring by intrinsic or extrinsic mechanisms. </p>\n<p><strong>Statins</strong>, such as <strong>atorvastatin</strong> are started because they <strong>reduce the risk of recurrence of NSTEMI</strong> and <strong>stabilize the atherosclerotic plaque</strong> in the coronary arteries.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9623",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a history of consumption of 2-3 drinks per week comes with complaints of right upper quadrant discomfort. He has grade 2 steatosis. His BMI was 29kg/m2 and AST and ALT levels were slightly elevated. What would you advise him?",
      "choices": [
        {
          "id": 1,
          "text": "Lifestyle modification and vitamin E"
        },
        {
          "id": 2,
          "text": "Ursodeoxycholic acid and lifestyle modification"
        },
        {
          "id": 3,
          "text": "Lifestyle modifications and weight loss"
        },
        {
          "id": 4,
          "text": "Pioglitazone and lifestyle modifications"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This patient with a history of consumption of <strong>2-3 alcoholic</strong> drinks per week(acceptable limit is <strong>&lt;5</strong> per week for men)presents with <strong>right upper quadrant</strong> discomfort with a BMI of <strong>29kg/m2</strong> and slightly <strong>elevated AST</strong> and <strong>ALT</strong> most likely has <strong>nonalcoholic fatty liver disease(NAFLD).</strong> The first line for management of this condition is to advise him on <strong>lifestyle modifications</strong> and <strong>vitamin E.</strong> All the other options include drugs that are used off-label but are <strong>not FDA-approved</strong> for use in NAFLD. </p>\n<p>Non-alcoholic fatty liver disease (NAFLD) is associated with <strong>diabetes</strong> and <strong>obesity.</strong> The fatty change may also be caused due to the effect of <strong>toxins</strong> (including certain medications), <strong>protein malnutrition, dyslipidemia,</strong> and anoxia. Bleomycin, methotrexate, doxycycline, and l-Asparaginase are other drugs causing hepatic steatosis.</p>\n<p>Most of the patients with NAFLD and NASH are asymptomatic. They are usually <strong>diagnosed incidentally</strong> on routine blood work. Some patients with NASH can present with right upper quadrant pain due to stretching of the liver capsule from hepatomegaly, or <strong>acanthosis nigricans</strong> due to insulin resistance or with signs like palmar erythema, spider telangiectasia, jaundice, splenomegaly, and ascites if they have <strong>liver cirrhosis.</strong> Currently, a <strong>biopsy</strong> is the gold standard investigation to establish the diagnosis.</p>\n<p>The current approach to NAFLD management focuses on treatment to avoid or decrease the risk factors for NASH (like obesity, insulin resistance, metabolic syndrome, and dyslipidemia). For patients with morbid obesity, bariatric surgery can be done. In patients with decompensated cirrhosis, liver transplantation is can be considered. </p>\n<p>Note: The FDA in 2024 has approved <strong>Resmetirom</strong>, a thyroid hormone receptor-beta (THR-beta) agonist for noncirrhotic NASH with moderate to advanced fibrosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1077",
      "difficulty": "medium"
    },
    {
      "text": "The blood investigation of a patient is given below. What is the probabale diagnosis?<div class='question-desc-html'><ul>\n<li>HBsAg - NR</li>\n<li>Anti HBs - NR</li>\n<li>Anti HBc IgM - NR</li>\n<li>Anti HBc total - positive</li>\n<li>HBeAg - NR</li>\n<li>Anti HBe - NR</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute HBV infection in window period"
        },
        {
          "id": 2,
          "text": "Immune with recombinant HBV Vaccine"
        },
        {
          "id": 3,
          "text": "HBV infection in the remote past, completely recovered"
        },
        {
          "id": 4,
          "text": "Chronic HBV infection - inactive carrier"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><br />The most probable diagnosis is <strong>remote</strong> infection with <strong>hepatitis B virus (HBV).</strong></p>\n<p>A non-reactive HbsAg rules out active HBV infection<strong> (Options D).</strong></p>\n<p>Non-reactive IgM anti-HbcAg suggests that the patient is not in the window period <strong>(Option A).</strong></p>\n<p>The absence of Anti HbS makes vaccination unlikely.(<strong>Option B</strong>)</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1052",
      "difficulty": "medium"
    },
    {
      "text": "The given image shows a normal graph on the left and the patient's graph on the right. Which of the following diagnoses can be inferred from the graph?",
      "choices": [
        {
          "id": 1,
          "text": "Chest wall neuromuscular disease"
        },
        {
          "id": 2,
          "text": "Sarcoidosis"
        },
        {
          "id": 3,
          "text": "Idiopathic pulmonary fibrosis"
        },
        {
          "id": 4,
          "text": "Bronchiectasis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient’s graph shows a <strong>reduction</strong> in both<strong> FVC &amp; FEV1/FVC </strong>which is <strong>&lt; 70%</strong>, indicating an <strong>obstructive lung disorder</strong>. Therefore, the most likely diagnosis is <strong>Bronchiectasis</strong>.</p>\n<p><strong>Chest neuromuscular disease</strong> (option A), <strong>sarcoidosis</strong> (option B) &amp; <strong>idiopathic pulmonary fibrosis</strong> (option C) are <strong>restrictive</strong> lung disorders, where there is a reduction of <strong>FVC to &lt; 4L</strong>, Without a loss in FEV1/FVC ratio (normal or &gt;70%).</p>\n<p>These values are measured as a part of the <strong>pulmonary function test</strong> known as <strong>spirometry</strong>. At a given lung volume, when a person inhales to the total lung capacity and<strong> exhales</strong> as hard and <strong>completely</strong> as possible, the volume of expired air is recorded as <strong>forced vital capacity (FVC)</strong>, and the volume of <strong>air expired</strong> in the<strong> first second</strong> is called the <strong>forced expiratory volume (FEV1)</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ffbd97e6efff47eda6268df1bde7ed6fx1280x1110.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: PFT for obstructive vs restrictive diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>PFT</strong></p>\n</td>\n<td>\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td>\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FVC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEV1</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td>\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td>\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEF 25-75</p>\n</td>\n<td>\n<p>&lt;50% predicted</p>\n</td>\n<td>\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TLC</p>\n</td>\n<td>\n<p>Normal/ increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RV</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DLCO</p>\n</td>\n<td>\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p><hr><h3>Related Pearl: Lung volumes and capacities</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Measurement</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Normal Value</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tidal volume (TV)</strong></p>\n</td>\n<td>\n<p>The amount of air that moves into the lungs with each inspiration (or the amount that moves out with each expiration) during quiet breathing</p>\n</td>\n<td>\n<p>500&ndash;750 mL.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory reserve volume&nbsp;</strong><strong>(IRV)</strong></p>\n</td>\n<td>\n<p>The air inspired with a maximal inspiratory effort in excess of the TV</p>\n</td>\n<td>\n<p>&sim;3 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory reserve volume (ERV)</strong></p>\n</td>\n<td>\n<p>The volume expelled by an active expiratory effort after passive expiration</p>\n</td>\n<td>\n<p>&sim;1.1 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Residual volume (RV)</strong></p>\n</td>\n<td>\n<p>The air left in the lungs after a maximal expiratory effort</p>\n</td>\n<td>\n<p>&sim;1.2 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total lung capacity (TLC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV+RV</p>\n</td>\n<td>\n<p>&sim;5.8 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vital capacity (VC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV</p>\n</td>\n<td>\n<p>&sim;4.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory capacity (IC)</strong></p>\n</td>\n<td>\n<p>TV+IRV</p>\n</td>\n<td>\n<p>&sim;3.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory capacity (EC)</strong></p>\n</td>\n<td>\n<p>TV+ERV</p>\n</td>\n<td>\n<p>&sim;1.6 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Functional residual capacity (FRC)</strong></p>\n</td>\n<td>\n<p>ERV+RV</p>\n</td>\n<td>\n<p>&sim;2.3 L</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/06c833b7f0ac40998f328de5bbe2816bx1279x973.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/09f02c63497141728eaf19b02048faeb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7506",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following malignancies, a liver transplantation is not contraindicated?",
      "choices": [
        {
          "id": 1,
          "text": "Renal carcinoma"
        },
        {
          "id": 2,
          "text": "Breast carcinoma"
        },
        {
          "id": 3,
          "text": "Melanoma"
        },
        {
          "id": 4,
          "text": "Testicular cancer"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 2111\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Liver transplantation</strong> is <strong>relatively not contraindicated</strong> in <strong>testicular cancer</strong>. Past history of malignancy is a relative contraindication to transplantation, because the effect of surgery and resulting immunosuppression may predispose the patient to early recurrence of the tumor.</p>\n<div class=\"page\" title=\"Page 2111\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Testicular carcinoma</strong> has a relatively <strong>low risk</strong> of <strong>recurrence</strong> (0%-10%) following transplantation. In contrast, renal carcinoma, breast carcinoma, and melanoma pose a higher risk of recurrence, exceeding 10%.</p>\n<p> </p>\n<p> </p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1073",
      "difficulty": "hard"
    },
    {
      "text": "A patient with CKD with refractory hypertension is brought to the casualty with dizziness. His BP was found to be 200/120mmHg.  His BUN was 50mg/dl and creatinine was 3mg/dl. Potassium was 6mEq/L. Which of the following is an indication of emergency hemodialysis?",
      "choices": [
        {
          "id": 1,
          "text": "Severe acidosis with elevated BUN and creatinine"
        },
        {
          "id": 2,
          "text": "Hypertension"
        },
        {
          "id": 3,
          "text": "Potassium level of 6mEq/L"
        },
        {
          "id": 4,
          "text": "Metabolic alkalosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Severe acidosis with elevated BUN</strong> and <strong>creatinine</strong> with symptoms like dizziness and altered mental status is an indication for hemodialysis. </p>\n<p>The <strong>emergent indications</strong> of dialysis or renal replacement therapy can be remembered by the <strong>mnemonic</strong> - '<strong>AEIOU</strong>' (vowels in the English alphabet). These include:</p>\n<ul>\n<li>Severe metabolic <strong>A</strong>cidosis ( pH &lt; 7.1) with concomitant renal injury (Option D).</li>\n<li><strong>E</strong>lectrolyte abnormalities - Severe hyperkalemia (&gt;6.5 mmol/L) or rapidly rising potassium levels (Option C).</li>\n<li><strong>I</strong>ntoxication - In cases of severe poisoning of toxic substances like <strong>methanol</strong> or ethylene glycol, and in cases of overdose with a dialyzable drug.</li>\n<li>Fluid <strong>O</strong>verload that is not responsive to diuretic therapy.</li>\n<li><strong>U</strong>remia - elevated BUN with signs and symptoms of uremia like bleeding, pericarditis, and altered mental status.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0088",
      "difficulty": "medium"
    },
    {
      "text": "What is the diagnosis in the ECG shown below?",
      "choices": [
        {
          "id": 1,
          "text": "First degree heart block"
        },
        {
          "id": 2,
          "text": "Third degree heart block"
        },
        {
          "id": 3,
          "text": "Wenckeback heart block"
        },
        {
          "id": 4,
          "text": "Mobitz type 2 block"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The ECG shown above shows regular <strong>PR intervals</strong> with a <strong>sudden dropped beat.</strong> This indicates a <strong>second-degree atrioventricular block, Mobitz type 2.</strong></p>\n<p><strong>Second Degree Heart Block</strong>: It occurs due to the intermittent failure of electrical impulse conduction from the atrium to the ventricle. It is characterized by a missed QRS. It is of two types:</p>\n<ul>\n<li><strong>Mobitz type 1/Wenckebach</strong> occurs due to the decremental conduction of electrical impulses in the AV node. It is characterized by a progressive PR elongation leading to an eventual drop in the QRS complex. This may be seen in young athletes.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eeba5011417b4da7a5c8584dc8401b57x436x135.PNG\" alt=\"Explanation Image\"><ul>\n<li>Mobitz type 2 occurs in the distal or infra-His conduction system and is often associated with intraventricular conduction delays. It is characterized by an <strong>intermittent failure</strong> of conduction of the P wave without any change in the preceding impulses. On ECG there is a <strong>fixed PR interval</strong> and <strong>missed QRS.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fe5f3695d29449e391e74d1f2dd270b5x442x133.PNG\" alt=\"Explanation Image\"><p>Other options: </p>\n<p>Option A: In a first-degree AV block, a <strong>prolonged PR interval</strong> (of over 200 ms) is seen which indicates a <strong>slowing</strong> of <strong>conduction</strong> between the atria and ventricles, usually due to <strong>slow conduction</strong> through the atrioventricular node (AV node). </p>\n<p>Option B: <strong>Third-degree</strong> heart block presents as a <strong>complete dissociation</strong> between the P wave and the QRS complex and occurs due to <strong>complete blockage</strong> of transmission of impulses from the AV node to the ventricles. Here, the ventricles assume an <strong>idioventricular rhythm</strong> and do not correlate to the P waves. </p>\n<p> </p><hr><h3>Related Pearl: Types of Heart block</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/321f89fee89642ff8d4791a7741dd90ax1280x1311.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Normal ECG waves and intervals</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>ECG wave/interval</strong></p>\n</td>\n<td>\n<p><strong>Physiological correlates</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>P wave</p>\n</td>\n<td>\n<p>Atrial depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QRS complex (up to 0.10s)</p>\n</td>\n<td>\n<p>Ventricular depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T wave</p>\n</td>\n<td>\n<p>Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>U wave</p>\n</td>\n<td>\n<p>Repolarization of ventricular myocytes with long action potential</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PR interval&nbsp; (0.12-0.2s)&nbsp;</p>\n</td>\n<td>\n<p>Atrial depolarization and conduction through AV node</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>QT interval&nbsp; (up to 0.43s)</p>\n</td>\n<td>\n<p>Ventricular depolarization and Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST interval (Average 0.32s)</p>\n<p>(QT minus QRS)</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential+ Ventricular repolarisation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ST segment</p>\n</td>\n<td>\n<p>Plateau portion of ventricular action potential</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/70e10acc7b9f4c249713071ae9311e21x1280x1789.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/aa48441f5b7d44109b74845aec7e75b3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0988",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man with a known history of diabetes mellitus presents with a BP of 150/90 and dizziness. What is the best way to manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Diet, Exercise, Lifestyle modification + Metoprolol"
        },
        {
          "id": 2,
          "text": "Diet, Exercise, Lifestyle modification  + amlodipine"
        },
        {
          "id": 3,
          "text": "Diet + prazosin"
        },
        {
          "id": 4,
          "text": "Diet, Exercise, Lifestyle modification"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">In this patient with diabetes mellitus with new-onset hypertension, he should be advised <strong>conservative measures</strong> along with <strong>amlodipine </strong>for controlling his blood pressure.</p>\n<p class=\"p1\">Patients with <strong>co-existing hypertension</strong> and <strong>diabetes</strong> are at increased risk of cardiovascular events. Thus blood pressure should be adequately controlled in these patients regardless of ASCVD 10 year risk.</p>\n<p class=\"p1\"><strong>Lifestyle modifications to manage hypertension:</strong></p>\n<ul>\n<li class=\"p1\">Attain and maintain a BMI of &lt;25 kg/sq m</li>\n<li class=\"p1\">A diet rich in fruits, vegetables, and <strong>low-fat</strong> dairy products with reduced content of saturated and total fat. Diet rich in potassium, calcium and magnesium. </li>\n<li class=\"p1\">Dietary salt &lt;6 grams/day</li>\n<li class=\"p1\">For those who drink alcohol, 2 or less drinks/day for men and 1 or less drink/day for women</li>\n<li class=\"p1\">Physical activity: Regular aerobic activity, eg, brisk waking for 30 min/day. </li>\n</ul>\n<p><strong>Prazosin</strong> would be contraindicated in this patient due to his history of dizziness as it can cause orthostatic hypotension. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1064",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old male presents with increased thirst and increased frequency and volume of urination. He has no other symptoms. His random blood sugar was 205mg/dl. What appropriate investigations should be done?<div class='question-desc-html'><p>i) HbA1c<br />ii) Urine ACR<br />iii) Echocardiography<br />iv) Fundoscopy<br />v) ECG<br />vi) Serum protein electrophoresis</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "i, ii, iii, v"
        },
        {
          "id": 2,
          "text": "i, ii, iv, vi "
        },
        {
          "id": 3,
          "text": "i, ii, iii, iv"
        },
        {
          "id": 4,
          "text": "i, ii, iv, v"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This patient presenting with <strong>increased thirst(polydipsia), increased urination(polyuria)</strong> and a <strong>random blood sugar</strong> of <strong>205</strong> makes a diagnosis of <strong>type</strong> <strong>2 diabetes mellitus</strong> likely. For a newly diagnosed case of diabetes, patients need to undergo other investigations to check for systemic progression of disease. These investigations include <strong>HbA1c, Urine albumin creatinine ratio, Fundoscopy,</strong> and <strong>ECG.</strong></p>\n<p>Diabetes can cause many microvascular and macrovascular complications and requires screening for these conditions. </p>\n<ul>\n<li>HbA1c is done to estimate the <strong>glycemic control</strong> over the last 3 months and helps guide further therapy. It should be done <strong>2-4 times</strong> per year based on the previous values.  </li>\n<li><strong>Urine albumin creatinine ratio</strong> is done to check if there is progression to <strong>diabetic kidney</strong> disease. It should ideally be done <strong>annually</strong> to check for kidney disease.</li>\n<li>Dilated fundoscopy should be done <strong>annually</strong> in <strong>diabetics</strong> to rule out diabetic retinopathy. For a <strong>newly diagnosed</strong> case of <strong>T2DM,</strong> fundoscopy should be <strong>done</strong> at the <strong>time</strong> of <strong>diagnosis</strong> and then every year till there is no diabetic retinopathy.</li>\n<li><strong>ECG</strong> should be done to check for <strong>resting electrolyte abnormalities</strong> in diabetics. Additionally, many diabetic patients also have <strong>co-existing hypertension</strong> so ECG is done to rule out left <strong>ventricular hypertrophy.</strong></li>\n<li>Testing for <strong>diabetic neuropathy</strong> should be done <strong>annually</strong> with the <strong>monofilament</strong> test.</li>\n<li>BP screening 2-4 times a year</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0990",
      "difficulty": "medium"
    },
    {
      "text": "A young child presented with nocturnal chest pain and a history of syncope at school. ECG revealed a cove pattern of ST elevation in V2 and V3. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Myocardial infarction"
        },
        {
          "id": 2,
          "text": "HOCM"
        },
        {
          "id": 3,
          "text": "Brugada syndrome"
        },
        {
          "id": 4,
          "text": "DCM"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A given clinical scenario of nocturnal chest pain and a history of syncope in a young kid along with ECG findings of <strong>coved ST-segment elevation of V1-V3, </strong>points towards the diagnosis of <strong>Brugada syndrome.</strong></p>\n<p>Brugada syndrome is an inherited sodium channelopathy (SCN5A mutation) and is most commonly seen in Southeast Asian males. The age of presentation is usually 40 years. This syndrome is characterized by an increased risk for sudden cardiac death due to polymorphic ventricular tachyarrhythmias. <strong>Implantable cardioverter-defibrillator</strong> is the treatment of choice.</p>\n<p>Brugada syndrome is associated with <strong>right bundle branch block</strong>. It is an inherited disease that predisposes patients to potentially life threatening arrythmias. </p>\n<p>The ECG below is depictive of Brugada syndrome with concave ST segments and negative T waves (to be seen in more than one anterior precordial leads, i.e., V<sub>1</sub>-V<sub>3</sub>)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be306bd6f6fd4cc08068642c7b672f3dx1159x572.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1448",
      "difficulty": "easy"
    },
    {
      "text": "A 26-year-old female presents to the ER with menorrhagia. She mentions that her father and sister also suffer from bleeding disorders. Which of the following is an autosomal dominant bleeding disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Factor X deficiency"
        },
        {
          "id": 2,
          "text": "Factor VIII deficiency"
        },
        {
          "id": 3,
          "text": "Factor IX deficiency"
        },
        {
          "id": 4,
          "text": "Von Willebrand Disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This patient's clinical features are suggestive of <strong>von-Willebrand disease.</strong> It is caused by a deficiency of the <strong>von-Willebrand factor</strong>. </p>\n<p>They are present within cytoplasmic vesicles called <strong>Weibel-Palade bodies.</strong></p>\n<p>Normal Platelet count, Prolonged BT, Normal PT, and Prolonged aPTT are seen in von-Willebrand disease. Factor VIII is found bound to the Von-Willebrand factor (vWF)  in the blood. Deficiency of vWF results in Factor VIII deficiency and prolongation of aPTT in this disease. Prolonged BT is due to abnormal platelet-mediated hemostasis.</p>\n<p><strong>vWF is also found in</strong></p>\n<ul>\n<li>Platelet granules (Less as compared to endothelial cells)</li>\n<li>Subendothelium, where it binds to collagen</li>\n</ul>\n<p>Von Willebrand disease is the<strong> most common inherited bleeding</strong> disorder in humans. The bleeding tendency is usually mild and manifests during surgical or dental procedures. The most common presenting symptoms are spontaneous bleeding from mucous membranes (epistaxis), excessive bleeding from wounds, or menorrhagia.</p>\n<p>It is usually transmitted as an autosomal dominant disorder, but rare autosomal recessive variants can be seen.</p>\n<p>Three types are recognized, with phenotypic variations:</p>\n<p><strong>Type 1 and type 3</strong> von-Willebrand disease are associated with <strong>quantitative defects</strong> in vWF.</p>\n<p><strong>Type 1</strong> is an <strong>autosomal dominant</strong> disorder characterized by a <strong>mild to moderate</strong> vWF deficiency, accounting for about 70% of all cases. It is associated with <strong>mild disease</strong>.</p>\n<p><strong>Type 3</strong> disease is an <strong>autosomal disorder</strong> resulting in little to <strong>no vWF synthesis</strong>. Because vWF stabilizes factor VIII in the circulation, factor VIII levels are also reduced in type 3 disease and the associated bleeding disorder is often <strong>severe</strong>.</p>\n<p><strong>Type 2</strong> von-Willebrand disease is characterized by <strong>qualitative defects in vWF.</strong> Type 2A is the most common. It is inherited as an autosomal dominant disorder.</p>\n<p>Other options:</p>\n<p>Factor X, VIII and IX deficiencies are all causes of hemophilias. These conditions manifest as prolonged bleeding after injuries, dental treatment and hemarthrosis. They are also additionally X-linked conditions so the presence of this condition in her <strong>father</strong> and <strong>sister</strong> makes X-linked transmission impossible. </p><hr><h3>Related Pearl: Summary of Laboratory findings in Hemostatic Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard&ndash; Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1005",
      "difficulty": "easy"
    },
    {
      "text": "A woman comes with complaints of hyperpigmentation of her palms after an adrenalectomy. She also has new onset vision deficits. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Nelson syndrome"
        },
        {
          "id": 2,
          "text": "Sheehan syndrome"
        },
        {
          "id": 3,
          "text": "Conn's syndrome"
        },
        {
          "id": 4,
          "text": "Addisons disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of <strong>hyperpigmentation</strong>, history of<strong> adrenalectomy</strong> and visual deficits indicating a probable <strong>pituitary adenoma</strong> points to the diagnosis of <strong>Nelson's syndrome</strong>. </p>\n<p>Nelson's syndrome is a rare complication of <strong>total</strong> <strong>bilateral</strong> <strong>adrenalectomy </strong>(TBA). TBA is a procedure used to control hypercortisolism in Cushing's disease (due to ACTH-secreting pituitary adenoma) when resection of the primary tumor is not possible.</p>\n<p>The loss of feedback inhibition of the hypothalamic-pituitary-adrenal axis following TBA increases CRH. This leads to stimulation of<strong data-stringify-type=\"bold\"> ACTH-secreting corticotroph cells</strong>, causing enlargement of the original pituitary tumor or formation of a new one.</p>\n<p>Nelson's syndrome is associated with a clinical triad of:</p>\n<ul>\n<li>Hyperpigmentation</li>\n<li>Excessive ACTH secretion</li>\n<li>Corticotroph adenoma</li>\n</ul>\n<p>Screening is done with <strong>fasting plasma ACTH levels</strong> and <strong>MRI</strong> <strong>brain</strong> performed at regular intervals. Prophylactic pituitary irradiation may be recommended to prevent its incidence. The primary treatment is <strong>transsphenoidal surgery</strong>. Patients will also require life-long glucocorticoid replacement, as they do not produce cortisol.</p>\n<div class=\"page\" title=\"Page 2728\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The use of steroidogenic inhibitors in the treatment of Cushing's disease has decreased the need for bilateral adrenalectomy these days.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Option B: <strong>Sheehan</strong> syndrome refers to <strong>panhypopituitarism.</strong> It classically follows <strong>massive postpartum hemorrhage</strong> and associated hypotension. The abrupt, severe <strong>hypotension</strong> leads to <strong>pituitary ischemia</strong> and necrosis. Patients with the most severe form develop <strong>shock</strong> due to pituitary <strong>apoplexy.</strong> Pituitary apoplexy is characterized by a sudden onset of <strong>headache, nausea, visual deficits,</strong> and <strong>hormonal dysfunction</strong> due to acute hemorrhage or infarction within the pituitary. </p>\n<p>Option C: <strong>Conn's</strong> syndrome or primary aldosteronism occurs due to <strong>aldosterone-secreting</strong> adrenal adenoma leading to mineralocorticoid excess. It is characterized by <strong>hypokalemia, hypomagnesemia, muscle weakness,</strong> proximal myopathy and muscle cramps.</p>\n<p>Option D: Addison's disease (primary adrenal insufficiency), most commonly caused by <strong>autoimmune adrenalitis</strong> presents with <strong>hyperpigmentation</strong> of the <strong>skin,</strong> especially in <strong>areas</strong> exposed to <strong>sunlight</strong> or prone to friction. This is due to excessive stimulation of melanocytes by the raised adrenocorticotropic hormone (ACTH). This is seen in chronic cases. However, there are no visual symptoms in Addison's disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1049",
      "difficulty": "medium"
    },
    {
      "text": "These findings are suggestive of which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Addison's disease"
        },
        {
          "id": 2,
          "text": "Gigantism"
        },
        {
          "id": 3,
          "text": "Acromegaly"
        },
        {
          "id": 4,
          "text": "Cushings syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical image of a man with <strong>mandibular enlargement</strong>, <strong>prognathism </strong>(protrusion of jaw), and jaw malocclusion suggests the diagnosis of <strong>acromegaly</strong>. </p>\n<p><strong>Acromegaly </strong>is a result of <strong>growth hormone hypersecretion</strong> due to a<strong> pituitary adenoma. </strong>It can also occur due to<strong> </strong>extra pituitary lesions.<strong> </strong>If growth hormone hypersecretion occurs <strong>before</strong> the fusion of the growth plates at<strong> puberty, </strong>it leads to<strong> gigantism. </strong></p>\n<p><strong>75g </strong>of <strong>oral glucose load</strong> is administered to the patient. The growth hormone levels are measured within <strong>1-2 hours</strong> after administration. Normally, <strong>GH </strong>should be <strong>suppressed</strong> to less than 0.4 ug/L after the oral glucose load. A <strong>failure of suppression</strong> of growth hormone confirms the diagnosis of acromegaly. In some patients, growth hormone levels may demonstrate a paradoxical rise. </p>\n<p><strong>Acral bony overgrowth </strong>in acromegaly manifests as <strong>frontal bossing, increased hand </strong>and <strong>foot size, mandibular enlargement, prognathism</strong>, and <strong>widened</strong> <strong>space</strong> between incisors. <strong>Soft tissue swelling</strong> results in increased <strong>heel pad thickness</strong>, <strong>coarse facial features</strong>, and a large fleshy nose.</p>\n<div class=\"page\" title=\"Page 2724\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Generalized <strong>visceromegaly</strong> is seen including <strong>cardiomegaly, macroglossia,</strong> <strong>thyroid enlargement</strong>, etc. Serious complications include <strong>diabetes mellitus</strong>, <strong>obstructive sleep apnoea</strong>, and increased risk of <strong>colonic polyps</strong> and<strong> cancer</strong>. </p>\n</div>\n</div>\n</div>\n</div>\n<p>Acromegaly can be treated by <strong>transsphenoidal resection </strong>of the tumor. It can also be managed medically by using <strong>octreotide </strong>(a somatostatin analog), <strong>pegvisomant </strong>(Growth Hormone receptor antagonist), <strong>dopamine agonists</strong> or <strong>radiation</strong>. </p>\n<p>Other options: </p>\n<p>Option A: <strong>Addison's disease</strong> is a primary <strong>adrenal insufficiency</strong> in which the adrenal is unable to secrete adequate amounts of <strong>cortisol</strong> (glucocorticoid), and <strong>aldosterone</strong> (mineralocorticoid). The features are <strong>fatigue, weight loss, anorexia, low blood</strong> pressure, postural hypotension, hypoglycemia, <strong>nausea, vomiting, abdominal pain, salt</strong> craving, <strong>hyponatremia</strong> and hyperkalemia.</p>\n<p>Option B: <strong>Pituitary gigantism</strong> is caused by the overproduction of growth hormone, before the closure of epiphysis. It usually does not present with <strong>prognathism</strong> as this occurs after the <strong>closure</strong> of the growth plates. It presents as <strong>longitudinal</strong> growth <strong>acceleration.</strong> It is a rare condition, caused mostly by pituitary adenoma</p>\n<p>Option D: Cushing syndrome results from chronic exposure to excess glucocorticoids. It presents with <strong>weight gain, central obesity, hypertension,</strong> and <strong>hypokalemia.</strong> Other clinical features include thin brittle skin with <strong>easy bruisability, purple stretch marks, diabetes, dyslipidemia,</strong> and osteopenia.</p>\n<p> </p><hr><h3>Related Pearl: Tests for Acromegaly</h3><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b8fcd6b5842840879c903b2488734b89.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0997",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old lady with diabetes mellitus comes with dizziness. Which of the following would be seen in a patient with hyperinsulinemia? ",
      "choices": [
        {
          "id": 1,
          "text": "Hyperketonemia"
        },
        {
          "id": 2,
          "text": "Increased amino acids "
        },
        {
          "id": 3,
          "text": "Raised glucose"
        },
        {
          "id": 4,
          "text": "Increased fatty acid synthesis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Insulin increases fatty acid synthesis in adipose tissue.</p>\n<div class=\"page\" title=\"Page 437\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Effects of insulin on various tissues:</strong></p>\n</div>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td><strong>Tissue</strong></td>\n<td><strong>Increases</strong></td>\n<td><strong>Decreases</strong></td>\n</tr>\n<tr>\n<td><strong>Adipose tissue</strong></td>\n<td>Increased glucose entry<br /><strong>Increased fatty acid synthesis</strong><br />Increased glycerol phosphate synthesis<br />Increased triglycerides deposition<br />Activation of lipoprotein lipase<br />Increased K+ uptake</td>\n<td>Inhibition of hormone-sensitive lipase</td>\n</tr>\n<tr>\n<td><strong>Muscle</strong></td>\n<td>Increased glucose entry<br />Increased glycogen synthesis<br />Increased amino acid uptake<br />Increased protein synthesis in ribosome<br />Increase ketone uptake<br />Increase K+ uptake</td>\n<td>\n<p>Decrease protein catabolism</p>\n<p>Decrease  release of glucogenic amino acids</p>\n</td>\n</tr>\n<tr>\n<td><strong>Liver</strong></td>\n<td>Increased protein synthesis<br />Increased lipid synthesis<br />Increased glycogen synthesis &amp; glycolysis</td>\n<td>\n<p>Decrease ketogenesis</p>\n<p>Decreased glucose output due to decreased gluconeogenesis</p>\n</td>\n</tr>\n<tr>\n<td><strong>General</strong></td>\n<td>Increased cell growth</td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1147",
      "difficulty": "medium"
    }
  ]
}